Nontoxic multinodular goitre

E4_GOITREMULTINOD

nodular goiter: Goiter characterized by discrete tissue mass(es) that may or may not produce thyroid hormones.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 E04.2
  • Hospital discharge: ICD-9 2411
  • Hospital discharge: ICD-8 241
  • Cause of death: ICD-10 E04.2
  • Cause of death: ICD-9 2411
  • Cause of death: ICD-8 241

2 out of 7 registries used, show all original rules.

8583

4. Check minimum number of events

None

8583

5. Include endpoints

None

8583

6. Filter based on genotype QC (FinnGen only)

8583

Control definitions (FinnGen only)

Control exclude
E4_THYROID

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E04
Name in latin
Struma atoxica multinodularis

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 61722 52630 8754
Only index persons 53558 46255 7303
Unadjusted period prevalence (%)
Whole population 1.32 1.51 0.24
Only index persons 1.51 1.70 0.28
Median age at first event (years)
Whole population 53.21 52.57 57.09
Only index persons 52.22 51.51 56.67

-FinnGen-

Key figures

All Female Male
Number of individuals 8583 7235 1348
Unadjusted period prevalence (%) 2.17 2.47 0.59
Median age at first event (years) 52.54 51.15 60.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
7696
Matched controls
76958
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
104
Kela drug reimbursment
Thyroid insufficiency
875.1
323.0
1917
29
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
102.4
323.0
1238
144
E03.89
ICD-10 Finland
Other specified hypothyroidism
227.9
323.0
511
24
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
211.9
323.0
1779
109
EP1AE
NOMESCO Finland
Neck ultrasound examination
7.8
323.0
1115
1635
24199
ICD-8 Finland
Non-toxic nodular goitre, Unspecified
+∞
323.0
1156
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
37.2
323.0
708
209
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
147.8
323.0
650
48
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
110.3
323.0
1443
161
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
33.7
323.0
454
143
H03BB01
ATC
carbimazole; oral
67.4
323.0
403
63
E04.0
ICD-10 Finland
Nontoxic diffuse goitre
220.5
323.0
437
21
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
36.6
323.0
630
187
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
2023.0
323.0
5999
132
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
570.2
323.0
381
7
2411A
ICD-9 Finland
Non-toxic nodular goitre, Non-toxic multinodular goitre
+∞
323.0
501
*
E03
ICD-10 Finland
Other hypothyroidism
74.8
323.0
677
99
H03AA01
ATC
levothyroxine sodium; systemic
92.9
323.0
4080
922
BAA60
NOMESCO Finland
Total thyroidectomy
1430.8
323.0
1406
12
T86
ICPC
Hypothyroidism/myxoedema
59.8
323.0
467
83
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
4276.8
323.0
792
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
154.6
321.8
340
23
2505
FHL
Bilateral resection (also used if total removal has been performed on the other side)
125.4
312.1
336
28
2504
FHL
Unilateral resection or enucleation
87.9
307.4
344
41
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
300.9
284.3
288
10
24110
ICD-8 Finland
Non-toxic nodular goitre, Sporadic
+∞
255.6
244
*
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
777.9
231.5
227
*
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
90.8
205.5
229
26
BAA20
NOMESCO Finland
Unilateral partial excision of thyroid gland
335.5
196.5
198
6
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
10.5
169.4
342
338
T81
ICPC
Goitre
50.4
158.1
192
39
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
528.6
157.4
156
*
BAA25
NOMESCO Finland
Bilateral partial excision of thyroid gland
+∞
156.8
150
*
E04.8
ICD-10 Finland
Other specified nontoxic goitre
115.9
146.6
159
14
D34
ICD-10 Finland
Benign neoplasm of thyroid gland
22.5
134.4
198
90
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
83.9
131.7
148
18
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
152.6
127.6
135
9
BAA50
NOMESCO Finland
Lobectomy and resection of contralateral lobe of thyroid gland
+∞
108.6
104
*
E04
ICD-10 Finland
Other nontoxic goitre
32.8
107.1
142
44
24100
ICD-8 Finland
Non-toxic nodular goitre, Endemic
+∞
106.5
102
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
519.8
103.9
103
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
94.7
3137
22392
106
Kela drug reimbursment
Hypoparathyroidism
57.6
91.3
108
19
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.1
86.5
525
1801
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
60.2
86.0
101
17
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
84.3
2066
13385
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
77.0
1668
10347
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
370.9
73.8
74
*
N02BE01
ATC
paracetamol; systemic, rectal
1.8
72.5
6634
59787
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
355.5
70.7
71
*
R13
ICD-10 Finland
Dysphagia
2.5
69.2
570
2350
2419X
ICD-9 Finland
Non-toxic nodular goitre, Unspecified non-toxic nodular goitre
+∞
68.8
66
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
3.4
68.0
354
1084
A11CC03
ATC
alfacalcidol; systemic
4.7
64.2
229
501
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
+∞
61.5
59
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
60.9
1638
10723
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
5.2
60.3
196
388
T72
ICPC
Benign neoplasm thyroid
21.5
57.4
85
40
E06.1
ICD-10 Finland
Subacute thyroiditis
+∞
57.3
55
*
R03AC02
ATC
salbutamol; inhalant
1.5
56.9
3786
30569
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
+∞
55.3
53
*
E83.51
ICD-10 Finland
Hypocalcemia
12.8
55.0
99
78
GB1AA
NOMESCO Finland
Tracheal X-ray examination
146.1
54.9
58
*
A02BC05
ATC
esomeprazole; systemic
1.5
51.7
3052
23874
A11CC02
ATC
dihydrotachysterol; oral
33.8
51.3
67
20
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
+∞
51.1
49
*
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
49.1
1981
14244
TBA20
NOMESCO Finland
Aspiration cytology of thyroid gland
+∞
49.0
47
*
2410A
ICD-9 Finland
Non-toxic nodular goitre, Non-toxic uninodular goitre
+∞
48.0
46
*
8330/3-C73.9
ICD-O-3
Follicular carcinoma, NOS, of thyroid gland
164.3
46.9
49
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
46.3
3074
24428
2506
FHL
Thyroidectomy
160.9
45.8
48
*
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
4.6
45.0
160
350
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
3.5
45.0
216
621
T85
ICPC
Hyperthyroidism/thyrotoxicosis
27.9
44.7
61
22
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
44.3
2084
15425
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
26.7
44.1
61
23
R01AD09
ATC
mometasone; nasal
1.4
44.1
3092
24751
G47.3
ICD-10 Finland
Sleep apnoea
1.6
43.7
1196
7782
BA1AE
SPAT
NA
8.9
42.1
91
103
ZXA05
NOMESCO Finland
Left side
1.5
41.5
1962
14503
4CJ01
NOMESCO Finland
NA
211.1
40.9
42
*
R06.0
ICD-10 Finland
Dyspnoea
1.5
40.7
1791
13024
E89.0
ICD-10 Finland
Postprocedural hypothyroidism
+∞
40.6
39
*
R49.01
ICD-10 Finland
Functional dysphonia
2.8
40.4
280
1042
ZXA00
NOMESCO Finland
Right side
1.5
40.3
2070
15538
E06.3
ICD-10 Finland
Autoimmune thyroiditis
20.1
40.0
60
30
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
88.5
39.8
44
5
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
64.6
39.1
45
7
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
38.7
2449
19105
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
56.5
38.3
45
8
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
+∞
37.5
36
*
J01DB01
ATC
cefalexin; oral
1.4
37.4
5831
52928
J01AA02
ATC
doxycycline; systemic
1.4
36.8
5763
52241
E05.1
ICD-10 Finland
Thyrotoxicosis with toxic single thyroid nodule
+∞
36.5
35
*
C07AB07
ATC
bisoprolol; oral
1.4
36.1
3379
28091
8341/3-C73.9
ICD-O-3
Papillary microcarcinoma of thyroid gland
359.0
36.0
36
*
J01FA10
ATC
azithromycin; systemic
1.3
34.9
3938
33658
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
5.6
34.8
103
185
A02BC02
ATC
pantoprazole; systemic
1.4
34.6
4744
41778
E07.9
ICD-10 Finland
Disorder of thyroid, unspecified
25.4
34.4
48
19
BAA30
NOMESCO Finland
Excision of thyroid isthmus
76.5
33.8
38
5
J01FA06
ATC
roxithromycin; oral
1.4
33.5
2898
23685
SPAT1153
SPAT
Removal of sutures
1.4
33.5
2284
17941
24099
ICD-8 Finland
Simple goitre, Unspecified
+∞
33.3
32
*
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.7
31.6
224
846
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
12.8
31.5
56
44
WX402
NOMESCO Finland
General anaesthesia
1.5
31.4
1080
7385
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
6.8
31.3
80
119
S18
ICPC
Laceration/cut
1.3
30.7
2893
23863
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
30.3
1232
8737
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
30.0
4246
37153
UJF32
NOMESCO Finland
Coloscopy
1.4
29.5
1834
14109
BA1NN
NOMESCO Finland
I-131 dose capsel measurement
+∞
29.2
28
*
M79.6
ICD-10 Finland
Pain in limb
1.3
29.0
2525
20525
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
28.8
1832
14143
R07.0
ICD-10 Finland
Pain in throat
2.0
28.8
381
1948
SPAT1263
SPAT
Sampling
1.3
28.6
2900
24103
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
28.6
1406
10351
ZXA10
NOMESCO Finland
Bilateral
1.4
28.5
1369
10033
BWD00
NOMESCO Finland
Reoperation for deep haemorrhage in endocrine surgery
55.2
28.1
33
6
R53
ICD-10 Finland
Malaise and fatigue
1.4
27.7
1353
9938
M03BX02
ATC
tizanidine; oral
1.3
27.6
4211
37021
R03DC03
ATC
montelukast; oral
1.5
27.3
1058
7414
E20.8
ICD-10 Finland
Other hypoparathyroidism
75.4
26.8
30
*
T71
ICPC
Malignant neoplasm thyroid
272.0
26.7
27
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
26.6
1086
7685
M54.5
ICD-10 Finland
Low back pain
1.3
26.5
2151
17236
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
26.4
2518
20672
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
26.3
1415
10571
ZX114
NOMESCO Finland
Intramuscular
3.7
25.9
116
318
B01AB05
ATC
enoxaparin; parenteral
1.3
25.9
2189
17640
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.4
25.8
1246
9125
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
25.7
2642
21905
DQE10
NOMESCO Finland
Injection of foreign material into vocal cord
12.5
25.7
46
37
R42
ICD-10 Finland
Dizziness and giddiness
1.4
25.5
1576
12064
N02AX02
ATC
tramadol; systemic, rectal
1.3
25.3
2807
23513
H02AB06
ATC
prednisolone; systemic
1.3
25.3
3151
26813
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
25.2
3205
27347
R21
ICPC
Throat symptom/complaint
1.5
24.6
1089
7826
R49.08
ICD-10 Finland
Other specified dysphonia
2.6
24.6
181
701
ZSB00
NOMESCO Finland
Procedure related to previous procedure classified in chapter B
34.6
24.2
31
9
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
24.2
1141
8303
J37.0
ICD-10 Finland
Chronic laryngitis
2.3
24.2
224
979
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.6
24.0
666
4308
2440A
ICD-9 Finland
Acquired hypothyroidism, Postsurgical hypothyroidism
+∞
24.0
23
*
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
11.1
23.3
44
40
R01AD12
ATC
fluticasone furoate; nasal
1.3
23.1
1767
13972
2409X
ICD-9 Finland
Simple and unspecified goitre, Goitre, unspecified
22.1
22.9
33
15
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.6
22.9
671
4399
J01DA01
ATC
[U] cefalexin; systemic
1.3
22.7
4322
38620
BAA99
NOMESCO Finland
Other operation on thyroid gland
83.7
22.7
25
*
G44.2
ICD-10 Finland
Tension-type headache
1.5
22.6
894
6272
A02BC04
ATC
rabeprazole; oral
1.6
22.1
567
3591
A02BA02
ATC
ranitidine; systemic
1.4
22.0
1385
10606
SPAT1325
SPAT
Vaccination
1.3
21.8
2418
20134
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
21.7
2556
21457
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
21.6
2121
17365
19399
ICD-8 Finland
Malignant neoplasm of thyroid gland
220.5
21.6
22
*
A02BC03
ATC
lansoprazole; oral
1.3
21.5
2049
16704
N03AX12
ATC
gabapentin; oral
1.4
21.1
1020
7440
A12AA04
ATC
calcium carbonate; oral
3.3
21.1
109
337
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
21.1
1051
7716
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.5
20.9
764
5266
24599
ICD-8 Finland
Thyroiditis, Unspecified
+∞
20.8
20
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
20.7
1171
8789
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
20.7
423
2514
E20.9
ICD-10 Finland
Hypoparathyroidism, unspecified
25.5
20.4
28
11
R02
ICPC
Shortness of breath/dyspnoea
1.5
20.3
789
5508
GD6AD
NOMESCO Finland
CT of chest and neck
9.4
20.0
41
44
R01AD08
ATC
fluticasone; nasal
1.3
19.9
1772
14281
BA2AT
NOMESCO Finland
Biopsy of thyroid with ultrasound quidance
18.8
19.9
30
16
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
+∞
19.8
19
*
M02AA07
ATC
piroxicam; topical
1.3
19.7
2666
22703
M25.5
ICD-10 Finland
Pain in joint
1.3
19.7
1852
15041
UKC02
NOMESCO Finland
Cystoscopy
1.4
19.5
862
6176
N03AX16
ATC
pregabalin; oral
1.3
19.5
1571
12468
SPAT1312
SPAT
General health counselling
1.3
19.5
2040
16799
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
19.4
1534
12142
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
19.1
2537
21524
R51.80
ICD-10 Finland
Headache
1.4
19.1
870
6268
A02BC01
ATC
omeprazole; systemic
1.3
18.6
1872
15314
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.2
18.5
2995
25991
SPAT1301
SPAT
No procedures
1.3
18.4
2115
17602
J01MA02
ATC
ciprofloxacin; systemic
1.3
18.4
2485
21105
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.6
18.2
441
2751
GAB20
NOMESCO Finland
Median sternotomy
32.9
17.9
23
7
E06.9
ICD-10 Finland
Thyroiditis, unspecified
15.3
17.9
29
19
J01FA09
ATC
clarithromycin; systemic
1.3
17.9
2039
16942
M01AC06
ATC
meloxicam; systemic, rectal
1.3
17.8
2612
22387
8340/3-C73.9
ICD-O-3
Papillary carcinoma, follicular variant of thyroid gland
+∞
17.7
17
*
WX704
NOMESCO Finland
Intubation
1.6
17.7
440
2766
R05
ICD-10 Finland
Cough
1.3
17.6
1275
9941
E03.8
ICD-10 Finland
Other specified hypothyroidism
95.3
17.5
19
*
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
17.5
1965
16293
AA1AD
NOMESCO Finland
CT of head and brain
1.3
17.5
1531
12279
H04.10
ICD-10 Finland
Dry eye syndrome
1.5
17.5
652
4509
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
17.4
2820
24422
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
17.4
1998
16612
A12AA06
ATC
calcium lactate gluconate; oral
16.9
17.3
27
16
J01CA04
ATC
amoxicillin; systemic
1.3
17.3
5512
51414
C07AB02
ATC
metoprolol; systemic
1.3
17.2
1398
11086
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
17.2
1590
12840
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
17.2
4512
41164
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
17.1
3195
28091
SPAT1058
SPAT
PEF monitoring instruction
1.5
16.9
548
3679
C08CA01
ATC
amlodipine; oral
1.3
16.8
2410
20560
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
16.7
2115
17779
E05.89
ICD-10 Finland
Other thyrotoxicosis
+∞
16.7
16
*
N06AX11
ATC
mirtazapine; oral
1.3
16.6
2026
16953
Z50.5
ICD-10 Finland
Speech therapy
3.0
16.5
93
308
M01AE02
ATC
naproxen; oral, rectal
1.2
16.5
3713
33255
SPAT1310
SPAT
Counselling related to known health issue
1.3
16.4
2065
17338
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.3
16.3
1467
11787
N06AX21
ATC
duloxetine; oral
1.5
16.2
642
4496
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.7
16.1
369
2267
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
16.1
1505
12163
R5140
NOMESCO Finland
Monitoring the use of the aid
1.5
16.0
525
3528
S04
ICPC
Lump/swelling localized
1.5
15.9
567
3883
R03AC03
ATC
terbutaline; inhalant
1.4
15.9
901
6748
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
15.9
730
5262
R4130
NOMESCO Finland
Speech therapy
2.4
15.8
138
592
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
15.7
1666
13676
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
6.8
15.7
39
58
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
15.6
635
4469
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
15.6
1257
9939
XKD00
NOMESCO Finland
Uroflowmetry
1.5
15.6
590
4092
L01
ICPC
Neck symptom/complaint
1.4
15.5
864
6452
L17
ICPC
Foot/toe symptom/complaint
1.3
15.4
1668
13727
WZC30
NOMESCO Finland
Teaching
1.4
15.4
789
5806
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.3
15.2
1243
9847
E21.0
ICD-10 Finland
Primary hyperparathyroidism
2.4
15.2
125
521
J02AC01
ATC
fluconazole; systemic
1.2
15.1
2911
25565
T90
ICPC
Diabetes non-insulin dependent
1.3
15.1
1344
10777
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
15.1
1774
14746
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
15.1
1402
11308
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
15.0
1241
9845
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.2
14.9
4183
38137
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
14.9
1778
14800
R06AE07
ATC
cetirizine; oral
1.2
14.6
2854
25080
E05.4
ICD-10 Finland
Thyrotoxicosis factitia
+∞
14.6
14
*
1930A
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]
+∞
14.6
14
*
24400
ICD-8 Finland
Myxoedema, (hypothyreosis) post therapiam
+∞
14.6
14
*
L15
ICPC
Knee symptom/complaint
1.3
14.6
1420
11518
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
14.5
2759
24164
C07AA05
ATC
propranolol; systemic
1.3
14.5
1140
8975
Z71.8
ICD-10 Finland
Other specified counselling
1.3
14.5
1421
11529
SPAT1260
SPAT
Consultation of another employee
1.3
14.5
1131
8896
WX110
NOMESCO Finland
Local anesthesy
1.2
14.5
4431
40684
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
14.2
1356
10967
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
14.2
454
3037
C09CA01
ATC
losartan; oral
1.3
14.1
1576
12997
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
14.1
863
6537
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
1.4
14.1
732
5394
R05FB02
ATC
cough suppressants and expectorants
1.2
14.0
2651
23190
T15
ICPC
THYROID LUMP/MASS
10.9
14.0
26
24
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
14.0
1352
10951
E66.8
ICD-10 Finland
Other obesity
1.7
13.9
266
1551
M54.6
ICD-10 Finland
Pain in thoracic spine
1.6
13.9
386
2492
R05
ICPC
Cough
1.3
13.9
1411
11500
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.6
13.9
407
2666
R06AX27
ATC
desloratadine; oral
1.3
13.8
1578
13049
R00.2
ICD-10 Finland
Palpitations
1.5
13.7
437
2919
C03CA01
ATC
furosemide; systemic
1.2
13.7
1858
15673
T78.4
ICD-10 Finland
Allergy, unspecified
1.8
13.6
247
1418
E83.50
ICD-10 Finland
Hypercalcemia
2.7
13.6
94
356
M01AB05
ATC
diclofenac; systemic, rectal
1.2
13.6
4468
41179
N02AJ06
ATC
codeine and paracetamol; systemic
1.2
13.5
2263
19526
J01FF01
ATC
clindamycin; systemic
1.3
13.5
1634
13597
R03BA02
ATC
budesonide; inhalant
1.3
13.5
1088
8595
M79.1
ICD-10 Finland
Myalgia
1.4
13.4
762
5701
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
13.4
3428
30837
205
Kela drug reimbursment
Chronic hypertension
1.2
13.4
1834
15482
WZA90
NOMESCO Finland
Other doctors statement
1.3
13.4
1332
10820
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
13.4
497
3436
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.4
13.3
818
6198
R03BA05
ATC
fluticasone; inhalant
1.3
13.3
1099
8708
A01
ICPC
Pain general/multiple sites
1.5
13.1
491
3397
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
13.1
3982
36373
M01AX17
ATC
nimesulide; oral
1.2
13.1
1705
14303
GD1AD
NOMESCO Finland
Thorax CT examination
1.8
13.1
238
1368
L03
ICPC
Low back symptom/complaint
1.3
13.0
1538
12760
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
12.9
1172
9398
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
2.6
12.9
94
369
A01AB09
ATC
miconazole; local oral
1.4
12.8
620
4511
H02AB09
ATC
hydrocortisone; systemic
2.5
12.8
100
408
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.3
12.7
978
7668
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.4
12.6
687
5105
JN5SN
NOMESCO Finland
NA
+∞
12.5
12
*
R03BA01
ATC
beclometasone; inhalant
1.3
12.5
886
6865
J01EA01
ATC
trimethoprim; systemic
1.2
12.5
1908
16277
J01FA15
ATC
telithromycin; oral
1.4
12.5
580
4189
Z01.7
ICD-10 Finland
Laboratory examination
1.4
12.5
655
4833
R31
ICD-10 Finland
Unspecified haematuria
1.5
12.4
451
3099
F45.8
ICD-10 Finland
Other somatoform disorders
1.6
12.4
341
2200
R52.9
ICD-10 Finland
Pain, unspecified
1.5
12.4
500
3516
XF404
NOMESCO Finland
Ambulatory ECG
1.4
12.3
555
3983
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.5
12.3
423
2874
M70.6
ICD-10 Finland
Trochanteric bursitis
1.3
12.3
925
7228
C10AA07
ATC
rosuvastatin; oral
1.2
12.3
1515
12618
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
12.3
6273
60020
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.3
12.3
891
6928
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.5
12.2
399
2680
R20.2
ICD-10 Finland
Paraesthesia of skin
1.5
12.2
372
2459
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.5
12.2
366
2411
J31.0
ICD-10 Finland
Chronic rhinitis
1.5
12.2
424
2887
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.6
12.2
285
1765
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
2.7
12.2
80
293
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
1.8
12.1
217
1241
N05BA04
ATC
oxazepam; oral
1.2
12.1
1568
13128
M01AH05
ATC
etoricoxib; oral
1.2
12.1
3875
35445
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
15.9
12.1
19
12
R60.0
ICD-10 Finland
Localized oedema
1.4
12.1
692
5182
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.6
12.1
297
1866
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.3
12.0
804
6171
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.5
12.0
424
2897
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
12.0
2901
25869
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.5
11.9
459
3196
SPAT1097
SPAT
Recording of ECG
1.3
11.9
959
7565
24210
ICD-8 Finland
Thyrotoxicosis with or without goitre, Toxic nodular goitre
6.8
11.9
29
43
C09DA01
ATC
losartan and diuretics; oral
1.4
11.9
666
4970
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
11.8
1225
9989
B02AA02
ATC
tranexamic acid; systemic
1.3
11.8
961
7588
UDQ02
NOMESCO Finland
Direct laryngoscopy
3.3
11.8
58
177
M79.0
ICD-10 Finland
Rheumatism, unspecified
1.7
11.8
239
1424
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.3
11.8
754
5749
R06.5
ICD-10 Finland
Mouth breathing
1.5
11.8
393
2654
C05AA08
ATC
fluocortolone; rectal, topical
1.3
11.7
892
6978
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.3
11.7
937
7385
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.2
11.7
1831
15642
J20
ICD-10 Finland
Acute bronchitis
1.4
11.7
576
4204
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.4
11.7
527
3783
J45
ICD-10 Finland
Asthma
1.4
11.7
588
4307
J46
ICD-10 Finland
Status asthmaticus
1.9
11.7
179
975
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.3
11.7
935
7372
K30
ICD-10 Finland
Functional dyspepsia
1.4
11.6
651
4857
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
11.6
1317
10855
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.4
11.6
538
3881
R03BA08
ATC
ciclesonide; inhalant
1.4
11.6
487
3449
K80
ICPC
Cardiac arrhythmia NOS
1.4
11.6
467
3284
E06.0
ICD-10 Finland
Acute thyroiditis
22.9
11.5
16
7
P01AB01
ATC
metronidazole; oral, rectal
1.2
11.5
2675
23740
C09CA06
ATC
candesartan; oral
1.3
11.5
1350
11174
M01AH01
ATC
celecoxib; oral (coxibs)
1.3
11.5
1220
9976
24209
ICD-8 Finland
Thyrotoxicosis with or without goitre, Cum struma diffuse NUD
+∞
11.5
11
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.3
11.4
1344
11124
XF402
NOMESCO Finland
ECG with work load test
1.4
11.4
660
4954
R96
ICPC
Asthma
1.4
11.4
543
3941
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.4
11.3
459
3232
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
1.4
11.3
611
4537
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
11.2
3217
29071
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
2.6
11.2
79
305
Z01.2
ICD-10 Finland
Dental examination
1.2
11.2
2450
21615
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.3
11.2
720
5494
R04.2
ICD-10 Finland
Haemoptysis
1.9
11.2
169
917
A07AA02
ATC
nystatin; oral
1.5
11.2
409
2819
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.3
11.1
769
5933
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
2.7
11.1
74
275
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.3
11.1
750
5767
C08CA13
ATC
lercanidipine; oral
1.3
11.0
855
6704
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.7
11.0
219
1298
A10BA02
ATC
metformin; oral
1.2
11.0
1594
13501
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.4
11.0
617
4606
B01AA03
ATC
warfarin; systemic
1.3
10.9
1143
9323
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
2.2
10.9
107
490
A03FA02
ATC
cisapride; oral, rectal
1.4
10.8
504
3639
BBA20
NOMESCO Finland
Exploration of parathyroid gland
4.7
10.8
35
74
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
1.3
10.8
728
5594
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
1.8
10.8
185
1048
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.2
10.7
1614
13718
24409
ICD-8 Finland
Myxoedema, (hypothyreosis) NUD
21.5
10.7
15
7
R03AK07
ATC
formoterol and budesonide; inhalant
1.3
10.7
1089
8855
F51.0
ICD-10 Finland
Nonorganic insomnia
1.3
10.6
687
5243
A06AD11
ATC
lactulose; oral
1.3
10.6
855
6741
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.6
10.6
254
1587
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.4
10.6
572
4244
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.3
10.6
923
7356
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.3
10.6
966
7744
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.4
10.5
622
4681
M01AH02
ATC
rofecoxib; oral
1.3
10.4
901
7170
A04
ICPC
Weakness/tiredness general
1.3
10.4
752
5834
L28
ICPC
Limited function/disability (L)
1.3
10.4
1013
8185
8290/3-C73.9
ICD-O-3
Oxyphilic adenocarcinoma of thyroid gland
+∞
10.4
10
*
E06.5
ICD-10 Finland
Other chronic thyroiditis
+∞
10.4
10
*
UDC00
NOMESCO Finland
Ear microscopy
1.5
10.4
398
2770
WX725
NOMESCO Finland
Noninvasive ventilation
1.6
10.4
258
1627
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.4
10.3
481
3474
QX3LT
NOMESCO Finland
Subcutaneous sclerotherapy
12.0
10.3
18
15
207
Kela drug reimbursment
Chronic arrhythmias
1.3
10.3
869
6892
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
10.3
624
4717
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.3
10.3
868
6889
A98
ICPC
Health maint/preventive medicine
1.3
10.2
7044
68613
21899
ICD-8 Finland
Uterine fibroma
1.5
10.2
396
2762
R03BB04
ATC
tiotropium bromide; inhalant
1.4
10.2
524
3851
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.5
10.2
323
2157
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.4
10.2
598
4496
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.6
10.2
245
1530
R01AD01
ATC
beclometasone; nasal
1.3
10.2
911
7280
EP1AE
SPAT
NA
2.6
10.2
72
277
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.4
10.2
579
4333
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
10.2
1175
9693
H01
ICPC
Ear pain/earache
1.4
10.2
568
4237
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.3
10.2
642
4885
H93.1
ICD-10 Finland
Tinnitus
1.5
10.1
365
2512
L02
ICPC
Back symptom/complaint
1.4
10.1
508
3726
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.4
10.0
461
3329
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
2.5
9.9
75
303
E07.89
ICD-10 Finland
Other specified disorders of thyroid
16.7
9.9
15
9
J01DA06
ATC
[U] cefuroxime; systemic
1.3
9.8
869
6931
R12
ICD-10 Finland
Heartburn
1.4
9.8
409
2892
G04CA02
ATC
tamsulosin; oral
1.3
9.8
634
4839
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.3
9.8
828
6566
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.6
9.8
277
1805
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.4
9.8
557
4167
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.4
9.7
449
3238
D21
ICPC
Swallowing problem
2.3
9.7
83
357
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.5
9.7
308
2061
BA3AT
SPAT
NA
13.4
9.6
16
12
E03.1
ICD-10 Finland
Congenital hypothyroidism without goitre
55.0
9.6
11
*
E66.00
ICD-10 Finland
Metabolic syndrome
1.6
9.6
256
1644
M48.0
ICD-10 Finland
Spinal stenosis
1.3
9.6
771
6077
N06AX16
ATC
venlafaxine; oral
1.3
9.6
706
5495
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.3
9.5
673
5210
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
9.5
3426
31398
R11
ICD-10 Finland
Nausea and vomiting
1.4
9.5
462
3369
S29
ICPC
Skin symptom/complaint other
1.3
9.4
1022
8361
N40
ICD-10 Finland
Hyperplasia of prostate
1.4
9.4
550
4134
R51.81
ICD-10 Finland
Facial pain NOS
1.9
9.4
137
738
H062, E050
ICD-10 Finland
NA
+∞
9.4
9
*
24200
ICD-8 Finland
Thyrotoxicosis with or without goitre, Cum struma diffusa et exophthalmo. Morbus Basedowi
+∞
9.4
9
*
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.3
9.3
612
4685
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.3
9.3
578
4387
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.5
9.3
280
1852
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.4
9.3
414
2973
R07.3
ICD-10 Finland
Other chest pain
1.4
9.3
541
4066
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.3
9.2
773
6123
R49.03
ICD-10 Finland
Atrophic dysphonia
2.5
9.2
70
283
M47.9
ICD-10 Finland
Spondylosis, unspecified
1.7
9.2
192
1158
C10AA05
ATC
atorvastatin; oral
1.2
9.2
2381
21227
N06AA09
ATC
amitriptyline; systemic
1.3
9.2
644
4974
UJF30
NOMESCO Finland
Ileoscopy through colon
1.4
9.2
537
4035
C03DA01
ATC
spironolactone; oral
1.3
9.1
609
4673
L16
ICPC
Ankle symptom/complaint
1.3
9.1
575
4377
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.4
9.1
452
3308
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.3
9.1
691
5406
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
1.6
9.1
220
1380
103
Kela drug reimbursment
Diabetes, insulin-treated
1.2
9.1
1469
12554
N39.3
ICD-10 Finland
Stress incontinence
1.3
9.0
547
4140
R49.0
ICD-10 Finland
Dysphonia
2.1
9.0
101
493
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.4
9.0
465
3426
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.4
8.9
442
3229
R60.9
ICD-10 Finland
Oedema, unspecified
1.5
8.9
279
1861
M01AX05
ATC
glucosamine; oral
1.2
8.9
1535
13192
E07
ICD-10 Finland
Other disorders of thyroid
24.0
8.9
12
5
J38.4
ICD-10 Finland
Oedema of larynx
3.3
8.9
43
132
M79.7
ICD-10 Finland
Fibromyalgia
1.7
8.9
190
1151
R23
ICPC
Voice symptom/complaint
1.9
8.9
126
672
R74
ICPC
Upper respiratory infection acute
1.2
8.9
1488
12755
H60.3
ICD-10 Finland
Other infective otitis externa
2.0
8.9
112
574
K59.09
ICD-10 Finland
Constipation, unspecified
1.5
8.8
337
2347
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
1.8
8.8
149
841
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.2
8.8
1188
9957
SPAT1211
SPAT
Application of soft bandage
1.4
8.8
520
3915
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
8.8
1621
14016
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.4
8.8
464
3427
D01
ICPC
Abdominal pain/cramps general
1.3
8.8
589
4519
A01AB04
ATC
amphotericin B; local oral
1.5
8.8
326
2257
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.2
8.8
1450
12409
J45.1
ICD-10 Finland
Nonallergic asthma
1.4
8.8
395
2841
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.4
8.7
368
2614
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.3
8.7
754
5998
A02BA04
ATC
nizatidine; systemic
1.4
8.7
488
3642
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.5
8.7
254
1670
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
1.8
8.7
138
765
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.3
8.7
516
3892
G04BD04
ATC
oxybutynin; oral, transdermal
1.4
8.6
368
2617
R03AC13
ATC
formoterol; inhalant
1.5
8.6
289
1959
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
2.3
8.6
73
315
J38.7
ICD-10 Finland
Other diseases of larynx
3.6
8.6
37
104
D25.1
ICD-10 Finland
Intramural leiomyoma of uterus
1.4
8.5
394
2847
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.5
8.5
282
1908
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.6
8.5
219
1395
R52.2
ICD-10 Finland
Other chronic pain
1.7
8.5
178
1076
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
2.3
8.5
75
330
K02.1
ICD-10 Finland
Caries of dentine
1.2
8.5
3268
30003
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
2.4
8.4
71
302
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.3
8.4
612
4755
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.3
8.4
637
4977
E03.3
ICD-10 Finland
Postinfectious hypothyroidism
90.1
8.4
9
*
D17.2
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
1.9
8.4
124
670
45499
ICD-8 Finland
Varicose veins of lower extremities, Other and unspecified, without ulcer
1.3
8.4
532
4053
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.3
8.3
770
6175
BA1AQ
NOMESCO Finland
Thyroid SPECT with low dose CT
+∞
8.3
8
*
E03.4
ICD-10 Finland
Atrophy of thyroid (acquired)
+∞
8.3
8
*
2449X
ICD-9 Finland
Acquired hypothyroidism, Unspecified hypothyroidism
+∞
8.3
8
*
H06.2
ICD-10 Finland
Dysthyroid exophthalmos
+∞
8.3
8
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.4
8.3
337
2375
B01AF02
ATC
apixaban; oral
1.3
8.3
572
4410
M54
ICD-10 Finland
Dorsalgia
1.3
8.3
606
4713
D24
ICD-10 Finland
Benign neoplasm of breast
1.8
8.3
137
773
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.2
8.2
984
8139
SPAT1043
SPAT
Audiometry
1.3
8.2
630
4928
J35.0
ICD-10 Finland
Chronic tonsillitis
1.6
8.2
200
1261
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.4
8.2
389
2825
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
2.0
8.2
97
484
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.3
8.2
567
4378
A10BK03
ATC
empagliflozin; oral
1.4
8.1
319
2235
SPAT1336
SPAT
Request for examination
1.6
8.1
215
1382
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
1.4
8.1
461
3451
J34.2
ICD-10 Finland
Deviated nasal septum
1.6
8.1
195
1223
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.4
8.0
471
3542
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.2
8.0
2364
21241
-
ICD-10 Finland
NA
1.8
8.0
142
817
R09
ICPC
Sinus symptom/complaint
1.4
8.0
416
3067
R06AE09
ATC
levocetirizine; oral
1.3
8.0
788
6376
C01BC04
ATC
flecainide; systemic
1.6
8.0
191
1200
N64.4
ICD-10 Finland
Mastodynia
1.7
7.9
157
934
X59
ICD-10 Finland
Exposure to unspecified factor
1.2
7.9
969
8040
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
1.9
7.9
108
572
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.3
7.8
535
4120
R49.09
ICD-10 Finland
Unspecified dysphonia
2.3
7.8
70
308
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.4
7.8
368
2668
D18.0
ICD-10 Finland
Haemangioma, any site
1.8
7.8
125
694
A77
ICPC
Viral disease other/NOS
1.7
7.8
147
862
K59.0
ICD-10 Finland
Constipation
1.4
7.8
309
2172
M01AG02
ATC
tolfenamic acid; oral, rectal
1.2
7.8
955
7924
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
1.6
7.8
200
1278
J38.3
ICD-10 Finland
Other diseases of vocal cords
2.5
7.7
57
227
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.2
7.7
913
7542
SPAT1262
SPAT
Handing over of treatment supplies
1.2
7.7
989
8241
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.3
7.7
697
5574
C739
ICD-10 Finland
NA
45.0
7.7
9
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
7.7
792
6438
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.6
7.7
193
1227
N01
ICPC
Headache
1.3
7.6
471
3573
F29
ICPC
Eye symptom/complaint other
1.3
7.6
454
3423
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
2.9
7.6
44
152
D06
ICPC
Abdominal pain localized other
1.3
7.6
450
3392
H57.1
ICD-10 Finland
Ocular pain
1.7
7.6
162
984
RL210
NOMESCO Finland
NA
3.3
7.6
35
105
R29
ICPC
Respiratory symptom/complaint other
1.4
7.6
316
2244
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.2
7.5
1193
10155
TPH07
NOMESCO Finland
Cathetrisation of artery
1.3
7.5
556
4329
P06
ICPC
Sleep disturbance
1.3
7.5
472
3592
EMB10
NOMESCO Finland
Tonsillectomy
1.6
7.5
191
1218
M01AC01
ATC
piroxicam; systemic, rectal
1.2
7.5
837
6868
XA402
NOMESCO Finland
ENMG
1.7
7.5
135
783
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.1
7.4
2694
24554
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
1.3
7.4
699
5624
WX723
NOMESCO Finland
CPAP therapy
1.7
7.4
141
831
N30.0
ICD-10 Finland
Acute cystitis
1.2
7.4
953
7950
L08
ICPC
Shoulder symptom/complaint
1.2
7.3
1136
9648
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
3.1
7.3
37
119
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.6
7.3
181
1148
SPAT1285
SPAT
Provision of consultation response
1.4
7.3
298
2105
H02AB04
ATC
methylprednisolone; systemic
1.2
7.3
881
7291
M14.5*E03.9
ICD-10 Finland
Arthropathy in hypothyroidism (E00-E03+)
+∞
7.3
7
*
24509
ICD-8 Finland
Thyroiditis, Unspecified
+∞
7.3
7
*
E8901, C7391
ICD-10 Finland
NA
+∞
7.3
7
*
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.2
7.3
969
8107
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
2.0
7.2
88
446
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
1.5
7.2
202
1317
M47.82
ICD-10 Finland
Other spondylosis, cervical region
1.5
7.2
223
1488
H13
ICPC
Plugged feeling ear
1.2
7.2
1035
8722
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.3
7.2
601
4763
L86
ICPC
Back syndrome with radiating pain
1.4
7.2
323
2326
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.3
7.2
650
5202
U07
ICPC
Urine symptom/complaint other
1.4
7.2
334
2421
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
4.6
7.2
23
50
6481B
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Thyroid dysfunction[HYPOTHYREOSIS IN GRAVIDITATE]
30.0
7.1
9
*
K11.2
ICD-10 Finland
Sialoadenitis
1.6
7.1
166
1035
R4110
NOMESCO Finland
Physiotherapy
1.2
7.1
1626
14298
SDA02
NOMESCO Finland
Parodonthologic therapy
1.2
7.1
1921
17121
H53.1
ICD-10 Finland
Subjective visual disturbances
1.4
7.1
343
2504
E21.2
ICD-10 Finland
Other hyperparathyroidism
3.2
7.1
34
106
L82
ICD-10 Finland
Seborrhoeic keratosis
1.2
7.0
1000
8422
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.2
7.0
965
8097
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
1.4
7.0
266
1858
SPAT1216
SPAT
Assessment of functional ability
1.2
7.0
967
8120
N05CF01
ATC
zopiclone; oral
1.2
7.0
2077
18639
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
1.4
6.9
321
2324
S82
ICPC
Naevus/mole
1.3
6.9
683
5523
RP210
NOMESCO Finland
NA
5.1
6.9
20
39
E06
ICD-10 Finland
Thyroiditis
13.8
6.9
11
8
23914
ICD-8 Finland
Neoplasm of unspecified nature of other and unspecified organs, Glandulae thyreoideae
13.8
6.9
11
8
R35
ICD-10 Finland
Polyuria
1.4
6.9
281
1991
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.1
6.9
2349
21290
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.6
6.8
182
1177
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.2
6.8
1416
12345
A11
ICPC
Chest pain NOS
1.3
6.8
442
3383
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.3
6.8
645
5194
-34
ICPC
Blood test
1.6
6.8
151
933
J01
ICD-10 Finland
Acute sinusitis
1.5
6.8
250
1738
2502
FHL
Thyroid exploration and possible biopsy
40.0
6.8
8
*
SPAT1254
SPAT
Administration of medicine
1.2
6.7
824
6833
N17
ICPC
Vertigo/dizziness
1.3
6.7
681
5528
XQ800
NOMESCO Finland
Prick test
1.4
6.7
363
2701
N05CF02
ATC
zolpidem; oral
1.2
6.7
1036
8801
2509
FHL
Other measure in this category
22.5
6.7
9
*
WX722
NOMESCO Finland
PEEP
1.5
6.6
197
1306
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.2
6.6
960
8097
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.4
6.6
327
2395
A10BH01
ATC
sitagliptin; oral
1.3
6.6
488
3803
M01AX01
ATC
nabumetone; oral
1.4
6.6
269
1903
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
2.8
6.6
39
140
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.1
6.6
2553
23328
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
3.2
6.5
31
96
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.4
6.5
307
2228
R03AK08
ATC
formoterol and beclometasone; inhalant
1.5
6.5
197
1310
DQE20
NOMESCO Finland
Implantation of foreign material in vocal chord
10.0
6.5
12
12
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.3
6.5
627
5056
A99
ICPC
Disease/condition unspecnature/site
1.3
6.5
430
3303
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.3
6.5
408
3111
L90
ICPC
Osteoarthrosis of knee
1.3
6.4
401
3051
C09CA03
ATC
valsartan; oral
1.3
6.4
480
3747
J01CA08
ATC
pivmecillinam; oral
1.1
6.4
3227
29967
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.2
6.4
1447
12700
SPAT1104
SPAT
Monitoring of emergency patient
1.4
6.4
359
2686
A60
ICPC
General and Unspecified, Result test/procedure
1.5
6.4
235
1631
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
2.3
6.4
53
230
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.3
6.4
514
4058
R06.4
ICD-10 Finland
Hyperventilation
1.9
6.4
83
433
N06AB04
ATC
citalopram; systemic
1.2
6.4
1274
11074
L12
ICPC
Hand/finger symptom/complaint
1.2
6.4
779
6460
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
1.6
6.3
159
1013
E22.0
ICD-10 Finland
Acromegaly and pituitary gigantism
8.1
6.3
13
16
L91.0
ICD-10 Finland
Hypertrophic scar
2.1
6.3
65
310
A05
ICPC
Feeling ill
1.4
6.3
238
1662
N30
ICD-10 Finland
Cystitis
1.3
6.3
461
3592
K07.60
ICD-10 Finland
Snapping jaw
1.4
6.3
238
1663
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.2
6.3
1146
9877
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.2
6.3
832
6959
Z25.1
ICD-10 Finland
Need for immunization against influenza
1.4
6.3
288
2088
BA1AN
NOMESCO Finland
Thyroid gland isotope imaging
+∞
6.2
6
*
24503
ICD-8 Finland
Thyroiditis, Chronica
+∞
6.2
6
*
24191
ICD-8 Finland
NA
+∞
6.2
6
*
E042, D440
ICD-10 Finland
NA
+∞
6.2
6
*
E01.0
ICD-10 Finland
Iodine-deficiency-related diffuse (endemic) goitre
+∞
6.2
6
*
M65.3
ICD-10 Finland
Trigger finger
1.5
6.2
223
1539
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
1.5
6.2
213
1459
2180A
ICD-9 Finland
Uterine leiomyoma, Submucous leiomyoma of uterus
1.3
6.2
451
3506
R04
ICPC
Breathing problem other
1.6
6.2
166
1076
SPAT1044
SPAT
Tympanometry
1.8
6.2
105
599
ZX120
NOMESCO Finland
Intravenous
1.3
6.2
503
3973
SAA03
NOMESCO Finland
Extended examination of mouth
1.1
6.2
2154
19517
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
3.1
6.2
31
101
UJC01
NOMESCO Finland
Scopy of lower throat
2.4
6.1
47
193
R03AC12
ATC
salmeterol; inhalant
1.4
6.1
246
1736
A10BH05
ATC
linagliptin; oral
1.4
6.1
239
1680
SFA00
NOMESCO Finland
Small filling
1.2
6.1
677
5552
R01AD05
ATC
budesonide; nasal
1.3
6.1
438
3402
S21
ICPC
Skin texture symptom/complaint
1.2
6.1
716
5907
D12
ICPC
Constipation
1.5
6.1
174
1144
R00.0
ICD-10 Finland
Tachycardia, unspecified
1.5
6.1
201
1363
N04BC05
ATC
pramipexole; oral
1.3
6.1
434
3366
S01GX01
ATC
cromoglicic acid; ophthalmic
1.2
6.1
1151
9948
K86
ICPC
Hypertension uncomplicated
1.2
6.1
737
6099
J39.2
ICD-10 Finland
Other diseases of pharynx
2.2
6.1
56
254
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
1.6
6.1
129
788
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
1.3
6.1
432
3352
SPAT1377
SPAT
Polysomnography
1.6
6.1
145
913
M54.2
ICD-10 Finland
Cervicalgia
1.3
6.1
357
2693
SPAT1257
SPAT
Teaching of medicine inhalation technique
1.5
6.0
197
1336
2260A
ICD-9 Finland
Benign neoplasm of thyroid gland[NEOPLASMA BENIGNUM GLANDULAE THYREOIDEAE]
4.4
6.0
20
46
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.3
6.0
548
4393

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
391
58
70.58
307.65
6.6
1.8
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
462
188
25.92
307.65
5.8
1.3
u/ml
52.2
211.5
1.11
161
27
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
592
800
7.87
307.65
1.5
1.2
iu/l
23.5
2.2
0.55
162
163
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
1647
2390
8.29
307.65
3.5
1.7
pmol/l
4.5
4.4
1.02
1475
2074
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
7596
54334
4.46
307.65
7.7
2.6
pmol/l
15.7
14.6
231.70
7121
48342
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
855
1690
5.51
307.65
1.4
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
5482
38443
2.18
249.39
7.3
6.0
mmol/l
1.2
1.2
16.28
4681
32181
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1444
5753
2.82
247.79
3.3
3.3
ng/l
65.5
89.7
21.34
1243
4845
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
987
3334
3.22
226.20
1.2
1.1
iu/ml
99.2
79.1
1.08
358
1080
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
7882
66136
3.35
219.88
9.1
3.6
mu/l
1.8
2.1
0.56
7402
59563
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
4925
34851
1.97
197.00
6.3
5.3
mmol/l
1.2
1.2
18.04
4541
31203
(3018418) pH of Serum or Plasma
3461
23208
1.82
148.89
4.8
3.7
ph
7.4
7.4
0.99
646
4241
(3015377) Calcium [Moles/volume] in Serum or Plasma
3686
26752
1.66
108.89
3.2
3.4
mmol/l
2.3
2.4
25.69
3209
22836
(3013707) Erythrocyte sedimentation rate by Westergren method
6426
54671
1.70
93.91
4.6
4.2
mm/h
12.8
13.6
4.92
5949
50220
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
4174
32359
1.56
86.61
2.5
2.2
nmol/l
79.4
79.9
0.55
3761
28577
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6523
57058
1.60
71.09
7.5
7.4
u/l
77.4
79.2
2.78
6170
53265
(3013826) Glucose [Moles/volume] in Serum or Plasma
5097
42448
1.49
68.07
4.4
4.3
mmol/l
6.7
6.7
0.10
4822
39679
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
4251
34193
1.48
67.16
3.9
3.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
344
1307
2.70
61.91
2.7
2.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
7738
71611
1.82
58.27
16.3
14.7
mg/l
21.1
23.6
9.63
6361
56639
(3044640) Blood type and Crossmatch panel - Blood
3063
23576
1.47
57.72
2.2
2.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
506
2386
2.19
56.46
2.3
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
3853
31282
1.42
52.92
2.3
2.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
7968
74743
1.92
52.79
19.1
16.8
mmol/l
139.9
139.7
15.91
7805
72745
(3023103) Potassium [Moles/volume] in Serum or Plasma
7976
74927
1.91
51.34
19.3
16.9
mmol/l
3.9
4.0
10.29
7803
72775
(3013650) Neutrophils [#/volume] in Blood by Automated count
4902
41716
1.41
50.28
8.4
9.2
e9/l
4.0
4.1
1.58
4246
36144
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
86
141
6.15
50.09
1.5
1.2
pmol/l
15.0
14.7
0.28
70
116
(3013115) Eosinophils [#/volume] in Blood
4373
36689
1.39
47.58
5.8
5.9
e9/l
0.2
0.2
0.32
3796
31833
(3019198) Lymphocytes [#/volume] in Blood
4316
36294
1.38
45.41
5.8
5.8
e9/l
1.9
1.9
0.39
3762
31542
(3001604) Monocytes [#/volume] in Blood
4214
35383
1.38
44.30
5.7
5.7
e9/l
0.6
0.6
1.99
3610
30154
(3006315) Basophils [#/volume] in Blood
4223
35569
1.37
43.02
5.7
5.8
e9/l
0.0
0.0
0.16
3622
30317
(3044889) 12 lead EKG panel
5792
51327
1.39
43.00
4.4
3.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
3608
29679
1.37
42.45
3.0
2.7
ug/l
105.3
124.4
6.53
3308
27162
(40761511) CBC panel - Blood by Automated count
7845
73915
1.71
41.88
16.4
13.7
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
958
6093
1.64
41.57
2.2
2.0
nmol/l
366.8
382.8
1.76
880
5533
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
7530
70278
1.58
41.15
5.3
4.6
mmol/l
6.0
5.9
3.33
6879
63237
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
3430
28096
1.37
40.96
4.0
3.7
ng/l
33.4
71.7
1.32
2388
19596
(3037467) Urinalysis macro (dipstick) panel - Urine
5742
51004
1.38
40.64
5.1
4.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
3938
33022
1.36
40.18
4.3
4.5
g/l
35.7
35.2
8.23
3630
30392
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
7177
66377
1.50
40.00
6.6
5.7
mmol/mol
40.1
39.7
3.87
6637
60585
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
4530
38838
1.35
39.83
5.5
6.0
umol/l
10.7
11.0
0.66
4297
36688
(3021601) Nitrite [Presence] in Urine by Test strip
4276
36399
1.35
39.10
6.2
5.4
estimate
0.0
0.0
0.15
787
6406
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1286
8890
1.53
38.81
5.1
4.9
mmol/l
1.1
1.0
1.81
1170
8192
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2777
22139
1.38
38.68
3.0
2.9
ng/l
1242.9
1443.7
1.76
2398
19023
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
968
6346
1.59
36.86
4.7
3.6
mmol/l
1.2
1.2
7.76
867
5495
(3009261) Glucose [Presence] in Urine by Test strip
4299
36812
1.34
36.85
4.7
4.0
estimate
0.0
0.0
1.60
771
6407
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2857
23051
1.36
36.32
2.5
2.4
u/l
58.5
58.8
0.07
2645
21013
(3035350) Ketones [Presence] in Urine by Test strip
4227
36166
1.33
36.14
4.6
4.0
estimate
0.0
0.0
0.57
777
6375
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
2087
16015
1.40
36.10
1.7
1.7
mg/l
1.1
1.3
2.96
1611
12351
(3002030) Lymphocytes/100 leukocytes in Blood
4009
34058
1.33
35.91
6.0
6.1
%
28.1
27.6
2.17
3722
31428
(3031040) Bacteria [#/volume] in Urine by Automated count
5614
50100
1.35
35.82
5.5
4.9
e6/l
1643.8
2412.5
0.58
93
670
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1592
11715
1.44
34.69
2.7
3.1
mmol/l
0.8
0.8
1.76
1461
10821
(3022096) Basophils/100 leukocytes in Blood
3804
32200
1.33
34.38
5.9
6.0
%
0.7
0.7
0.41
3522
29748
(3019069) Monocytes/100 leukocytes in Blood
3922
33361
1.32
34.17
6.2
6.3
%
8.5
8.5
0.36
3651
30964
(3006504) Eosinophils/100 leukocytes in Blood
3900
33186
1.32
33.72
5.9
6.0
%
2.8
2.8
0.33
3621
30642
(3018010) Neutrophils/100 leukocytes in Blood
3940
33596
1.32
33.47
5.8
5.9
%
57.3
57.7
0.93
3669
31132
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
7632
72032
1.54
33.17
5.6
5.0
mmol/l
2.7
2.8
2.75
7024
65272
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
7976
76074
1.68
33.06
11.7
10.7
u/l
23.6
24.0
1.64
7707
72932
(3032080) INR in Blood by Coagulation assay
3546
29927
1.32
31.88
10.1
8.8
inr
1.3
1.3
0.04
980
8237
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
7216
67532
1.43
30.96
15.4
13.8
ml/min/173m2
76.8
77.2
0.78
6057
55237
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
3705
31685
1.30
29.35
2.1
2.0
pmol/l
97.3
96.7
0.28
1837
15128
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
3254
27394
1.30
28.87
5.1
4.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
7453
70354
1.45
28.74
5.0
4.4
mmol/l
4.7
4.8
9.33
6858
64071
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
7396
69742
1.44
28.44
4.9
4.4
mmol/l
1.5
1.6
23.84
6756
63131
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1601
12196
1.38
27.88
1.3
1.3
u/ml
11.6
13.4
0.45
615
4475
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1946
15327
1.35
27.35
1.3
1.2
u/ml
1.1
1.5
1.38
531
3907
(40760892) CBC W Ordered Manual Differential panel - Blood
1880
14730
1.35
27.35
4.9
4.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
3661
31471
1.28
27.08
10.2
9.6
e9/l
0.0
0.0
1.70
3002
25529
(3013512) EKG study
2658
21948
1.31
26.68
4.3
3.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1662
12821
1.37
26.62
1.3
1.3
iu/ml
38.5
36.6
0.11
486
4148
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2223
17917
1.32
26.56
2.1
2.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1387
10442
1.39
25.71
1.5
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
7132
67122
1.37
25.19
4.4
3.9
mmol/l
1.3
1.3
6.92
6459
60171
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1911
15172
1.33
25.12
2.9
3.0
mmol/l
2.4
2.5
12.56
1694
13225
(3029937) Albumin [Presence] in Urine by Test strip
2372
19431
1.31
24.88
5.1
4.5
estimate
0.0
0.0
0.22
768
6299
(3007461) Platelets [#/volume] in Blood
8149
78756
1.69
24.50
25.5
21.6
e9/l
257.2
256.5
0.37
7961
76381
(3024731) MCV [Entitic volume]
8151
78787
1.69
24.40
25.4
21.5
fl
90.8
91.3
22.08
8065
77427
(3010813) Leukocytes [#/volume] in Blood
8152
78801
1.69
24.38
25.5
21.6
e9/l
6.7
6.7
0.05
7950
76131
(3002256) Pathology report gross observation
1322
9955
1.39
24.35
1.3
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
8151
78794
1.68
24.30
25.5
21.6
e12/l
4.5
4.4
30.45
7951
76127
(3035941) MCH [Entitic mass]
8150
78782
1.68
24.30
25.4
21.5
pg
30.1
30.3
19.87
8064
77415
(3026493) Urate [Moles/volume] in Serum or Plasma
2202
17916
1.31
24.15
2.7
2.5
umol/l
6325.3
5326.7
0.42
1876
15184
(3000963) Hemoglobin [Mass/volume] in Blood
8151
78807
1.68
24.11
25.7
21.7
g/l
133.0
132.0
10.61
8063
77458
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
92
287
3.23
23.76
2.0
1.6
nmol/l
17.7
17.2
0.21
85
270
(3018095) Leukocytes [#/volume] in Urine
3061
26031
1.27
23.67
4.2
3.6
e6/l
86.6
117.4
1.83
2175
17876
(3026782) Osmolality of Urine
1796
14243
1.33
23.57
3.0
2.8
mosm/kgh2o
495.2
520.2
0.49
1529
11987
(3033658) Prothrombin time (PT) actual/Normal
2267
18604
1.30
23.13
3.4
3.7
%
92.0
91.5
0.48
2210
18130
(3002385) Erythrocyte distribution width [Ratio]
6311
58595
1.29
22.87
20.1
17.9
%
13.8
13.8
0.08
6211
57284
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2690
22594
1.28
22.79
2.1
2.1
u/l
154.1
192.1
2.18
2506
21013
(42870588) Differential panel, method unspecified - Blood
2896
24563
1.27
22.60
5.5
5.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2225
18276
1.29
22.40
2.3
2.3
mg/l
3.1
3.1
0.80
1902
15507
(3020682) Albumin/Creatinine [Ratio] in Urine
2627
22163
1.27
21.06
4.0
3.8
mg/mmol
7.3
8.3
0.64
1565
12922
(40768797) Stomach Pathology biopsy report
1352
10435
1.35
21.05
1.3
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
3093
26609
1.25
20.95
3.6
3.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
2580
21758
1.27
20.66
3.1
3.0
mmol/l
6.6
6.6
0.04
2165
18004
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1970
16081
1.29
20.50
1.7
1.7
pmol/l
21366353.2
30452244.7
0.43
1596
13037
(3010838) Calcium [Moles/time] in 24 hour Urine
105
385
2.75
20.45
1.8
1.6
mmol/24h
6.0
6.1
0.04
11
27
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
28
36
7.80
20.39
3.0
1.2
pmol/l
14.7
23.3
—
10
10
(3012516) Albumin [Mass/volume] in Urine
2493
21047
1.26
19.54
3.3
3.1
mg/l
643.7
445.0
0.86
1478
12260
(4010399)
753
5326
1.45
19.52
1.5
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1943
15927
1.28
19.40
5.2
4.5
kg/l
1.0
1.0
0.08
272
2505
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
4842
44001
1.23
19.00
3.0
3.0
u/l
45.8
47.5
0.55
4464
40388
(3002582) Erythrocytes [#/volume] in Urine
2581
21966
1.25
18.67
3.5
3.2
e6/l
72.9
76.4
0.04
1982
16478
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1237
9609
1.34
18.23
8.2
7.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1227
9528
1.34
18.11
1.4
1.3
titre
468.5
556.7
1.23
274
2141
(3019225) pH of Specimen
1036
7857
1.36
17.86
5.1
4.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
2399
20348
1.25
17.67
3.3
3.1
e6/l
0.3
0.5
1.35
1827
15100
(3000850) Epithelial cells [#/volume] in Urine
1845
15271
1.27
16.64
2.7
2.6
e6/l
5.6
6.8
4.21
1602
13269
(3041096) Erythrocytes [Presence] in Urine by Automated
2207
18696
1.24
16.16
4.3
3.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
2315
19797
1.23
15.38
3.3
3.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
575
4048
1.45
15.23
1.4
1.3
u/ml
118.8
199.3
3.50
523
3693
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
4400
40074
1.20
15.20
2.8
2.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
2108
17893
1.24
14.95
4.5
3.9
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
433
2895
1.52
14.83
1.3
1.2
u/ml
0.5
1.3
1.82
37
280
(3011985) Renin [Units/volume] in Plasma
175
918
1.93
14.73
1.4
1.3
mu/l
38.1
52.2
1.00
158
817
(3027273) Bicarbonate [Moles/volume] in Venous blood
502
3496
1.46
14.07
3.5
3.0
mmol/l
25.8
25.4
1.86
481
3400
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
2267
19535
1.22
13.67
1.7
1.6
mmol/l
1.4
1.3
1.98
1927
16256
(3004119) Hemoglobin [Mass/volume] in Venous blood
596
4308
1.41
13.65
3.1
3.1
g/l
129.0
126.1
2.92
578
4205
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
122
579
2.12
13.59
1.3
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1582
13155
1.25
13.33
1.4
1.5
g/l
2.3
2.4
0.54
907
7467
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
418
2849
1.49
13.07
1.8
1.9
u/l
41.5
39.3
1.23
367
2472
(3022145) Colonoscopy Study observation
1038
8219
1.30
13.06
1.3
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
700
5236
1.37
13.05
1.3
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1528
12692
1.25
12.97
2.9
2.7
e6/l
1.2
1.6
0.77
867
7050
(3021960) Folate [Moles/volume] in Serum or Plasma
2106
18159
1.21
12.40
1.6
1.5
nmol/l
21.1
21.1
0.01
1815
15135
(3020630) Protein [Mass/volume] in Serum or Plasma
811
6252
1.33
12.37
2.2
2.7
g/l
66.0
66.2
0.51
721
5602
(3021387) Prolactin [Units/volume] in Serum or Plasma
218
1294
1.70
12.28
1.8
1.6
mu/l
288.5
295.7
0.13
194
1170
(3042936) Bacteria identified in Isolate by Culture
1220
9942
1.26
12.15
2.0
2.0
—
—
—
0
0
(3012544) pH of Venous blood
858
6696
1.31
11.98
3.5
3.5
ph
7.4
7.4
—
7
33
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
161
884
1.84
11.86
1.2
1.3
pmol/l
276.4
274.4
0.04
134
684
(3007853) Bacteria identified in Skin by Aerobe culture
1037
8321
1.28
11.71
1.9
1.7
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
1106
8947
1.27
11.69
5.5
6.3
mmol/l
104.3
104.1
0.33
1071
8755
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1396
11605
1.24
11.64
3.2
2.8
e6/l
4.1
3.9
0.19
751
6014
(3021447) Carbon dioxide [Partial pressure] in Venous blood
825
6454
1.31
11.31
3.5
3.5
kpa
5.9
5.8
1.16
795
6266
(3030981) Hyaline casts [#/volume] in Urine by Automated count
486
3521
1.40
11.00
3.2
2.6
e6/l
0.2
0.3
3.33
473
3416
(3002173) Hemoglobin [Mass/volume] in Arterial blood
852
6722
1.30
10.95
6.1
7.0
g/l
120.3
119.0
1.25
821
6473
(3019309) Folate [Moles/volume] in Red Blood Cells
1718
14685
1.21
10.87
1.8
1.7
nmol/l
1199.6
1188.0
0.18
1304
10852
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
163
925
1.78
10.82
1.3
1.3
nmol/l
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
6630
63436
1.20
10.75
17.8
16.0
%
39.0
38.7
2.10
4300
42995
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
67
274
2.46
10.68
1.6
1.6
nmol/l
4.9
4.8
0.02
53
228
(3002032) Base excess in Venous blood by calculation
818
6463
1.29
10.39
3.6
3.5
mmol/l
2.3
2.1
0.83
690
5304
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
179
1064
1.70
10.11
1.3
1.3
nmol/l
0.3
0.2
0.16
12
83
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
39
123
3.18
10.10
2.6
1.7
ug/l
1.3
1.1
0.13
34
117
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2518
22399
1.18
10.04
3.1
3.1
u/l
31.6
35.2
1.34
2381
21158
(3048689) Calprotectin [Mass/mass] in Stool
1036
8466
1.25
9.98
1.9
2.1
ug/g
127.6
130.2
0.08
806
6496
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
178
1065
1.69
9.83
1.3
1.3
nmol/l
0.6
1.7
0.52
170
1015
(3003396) Base excess in Arterial blood by calculation
1004
8217
1.25
9.53
5.6
6.3
mmol/l
1.5
1.2
1.32
806
6523
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1701
14694
1.20
9.46
3.9
3.7
ng/l
211.9
355.1
0.70
1316
11643
(3009214) Lutropin [Units/volume] in Serum or Plasma
156
912
1.72
9.39
1.3
1.2
u/l
15.6
15.9
0.08
121
744
(3035637) Corticotropin [Mass/volume] in Plasma
126
693
1.83
9.34
1.8
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
298
2035
1.48
9.33
5.2
4.7
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
894
7255
1.26
9.12
5.8
6.6
%
95.8
95.8
0.05
870
6971
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
998
8213
1.24
9.00
5.7
6.3
kpa
5.1
5.1
0.51
961
7813
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
782
6257
1.27
8.98
2.3
2.4
ug/l
5.3
6.0
0.52
673
5286
(3017181) Myelocytes/100 leukocytes in Blood
754
6006
1.28
8.98
4.1
4.0
%
1.0
0.9
0.36
216
1689
(40761535) Cells panel - Urine sediment
777
6214
1.28
8.96
3.9
3.6
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
996
8212
1.24
8.82
5.7
6.3
kpa
12.6
12.4
0.36
958
7816
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1005
8301
1.24
8.76
2.2
2.5
umol/l
7.7
8.3
0.31
847
7131
(3025159) Blasts/100 leukocytes in Blood
680
5363
1.29
8.76
4.2
4.1
%
0.7
0.3
0.27
161
1322
(3008152) Bicarbonate [Moles/volume] in Arterial blood
585
4524
1.31
8.72
6.7
6.5
mmol/l
24.9
24.8
0.42
547
4208
(4094501)
264
1789
1.49
8.61
1.1
1.1
—
—
—
0
0
(3000492) Spirometry study
761
6106
1.27
8.54
1.4
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
716
5708
1.28
8.47
4.2
4.0
%
0.1
0.2
0.12
192
1559
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
563
4356
1.31
8.37
1.3
1.3
au/ml
57.1
51.9
0.18
18
183
(3036603) Volume of Urine
90
461
1.96
8.33
1.5
1.5
ml
1697.5
1817.0
0.35
33
108
(3049717) Cytology report of Urine Cyto stain
331
2358
1.42
8.32
2.6
2.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
1305
11130
1.20
8.25
2.7
2.3
umol/l
12.8
12.4
0.88
1208
10218
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1210
10248
1.21
8.23
2.6
2.3
g/l
2.4
2.3
1.08
1127
9411
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
72
346
2.09
7.95
1.9
1.7
pmol/l
173.5
178.9
0.15
67
318
(3004588) Protein electrophoresis panel - Serum or Plasma
658
5239
1.28
7.87
2.2
2.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
907
7502
1.23
7.78
3.7
3.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
2193
19627
1.16
7.69
4.2
4.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
296
2099
1.42
7.67
1.5
1.6
g/l
1.2
1.2
0.24
276
1985
(3019060) Gas panel - Arterial blood
604
4775
1.28
7.65
4.2
4.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
158
982
1.62
7.63
1.3
1.3
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
288
2035
1.43
7.61
1.6
1.6
g/l
0.2
0.2
0.19
268
1921
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
962
8038
1.22
7.48
3.4
4.1
u/l
243.4
248.5
0.50
896
7534
(3025941) Bacteria identified in Stool by Culture
508
3941
1.31
7.43
1.3
1.3
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
314
2264
1.40
7.41
1.6
1.6
titre
273.7
332.3
0.13
15
106
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1131
9610
1.20
7.40
2.7
2.4
%
21.3
21.5
0.20
956
8114
(3026389) Candida sp identified in Specimen by Organism specific culture
184
1196
1.55
7.36
1.4
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
605
4813
1.28
7.30
2.3
2.4
au/ml
33.1
29.2
0.25
26
235
(3000494) Fungus identified in Specimen by Culture
991
8335
1.21
7.21
1.4
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
365
2719
1.36
7.08
1.4
1.3
iu/l
33.3
35.6
0.54
319
2374
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
454
3495
1.32
7.04
1.1
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
1156
9892
1.19
6.99
28.7
25.3
inr
1.3
1.4
0.27
119
1363
(3002179) Metamyelocytes/100 leukocytes in Blood
670
5425
1.25
6.98
3.9
3.9
%
0.7
0.6
0.23
148
1208
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
390
2948
1.34
6.88
1.1
1.1
u/ml
1.1
1.9
—
9
40
(40758558) Short blood count panel - Blood
2085
18729
1.15
6.82
6.0
6.9
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
67
334
2.01
6.77
1.4
1.6
ug/l
7.0
9.1
0.93
62
295
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
533
4214
1.28
6.77
1.5
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
219
1510
1.46
6.65
2.3
2.3
ug/min
118.1
74.3
0.51
117
837
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
862
7209
1.22
6.64
1.6
1.6
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
662
5386
1.25
6.61
3.2
2.9
kpa
4.4
4.5
0.54
639
5214
(3009445) Proteinase 3 Ab [Units/volume] in Serum
387
2942
1.33
6.58
1.5
1.5
u/ml
9.2
19.3
1.52
12
70
(4035726)
863
7228
1.22
6.55
1.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
360
2712
1.34
6.51
1.6
1.6
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
147
940
1.57
6.38
1.6
1.5
%
58.8
58.1
0.07
86
574
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
474
3723
1.29
6.36
6.9
8.3
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
281
2045
1.39
6.34
1.3
1.2
u/ml
10.2
37.9
3.15
15
140
(3025549) Creatine [Moles/time] in 24 hour Urine
20
56
3.58
6.30
1.6
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
2436
22221
1.13
6.24
3.3
2.9
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
677
5560
1.24
6.22
2.9
3.9
u/ml
54.0
66.0
0.25
649
5355
(1002224) Polysomnography panel
291
2139
1.37
6.19
1.1
1.1
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
422
3277
1.30
6.18
2.6
2.6
%
0.7
0.7
0.07
403
3153
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
216
1509
1.44
6.15
1.4
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
947
8050
1.20
6.15
2.3
2.4
%
1.8
1.8
1.25
837
7050
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
708
5850
1.23
6.14
2.9
2.6
ml/min/173m2
60.9
63.3
1.02
307
2370
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
217
1519
1.44
6.12
1.3
1.2
u/ml
35.0
48.0
0.67
22
187
(3017732) Neutrophils [#/volume] in Blood
609
4955
1.25
6.10
2.9
3.1
e9/l
4.3
4.0
1.16
464
3640
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
315
2355
1.35
6.02
2.5
2.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
815
6855
1.21
5.92
2.2
2.3
u/l
36.4
41.2
0.43
684
5819
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
250
1806
1.40
5.92
1.9
1.9
mg/l
11.4
11.7
0.21
226
1654
(3020891) Body temperature
376
2893
1.31
5.91
5.1
4.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
390
3025
1.30
5.78
4.4
4.7
%
1.6
1.6
0.23
373
2831
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
251
1823
1.39
5.77
1.4
1.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
387
3004
1.30
5.71
4.4
4.7
%
0.9
0.9
0.29
371
2812
(3022689) Creatine [Moles/volume] in Urine
39
171
2.29
5.51
1.2
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
491
3947
1.26
5.49
3.3
3.4
mmol/l
2.5
2.0
1.98
377
2978
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
131
851
1.55
5.37
1.3
1.3
u/l
29.4
35.0
1.02
98
701
(3017446) Testosterone [Moles/volume] in Serum or Plasma
228
1651
1.39
5.36
2.3
1.9
nmol/l
10.9
11.1
0.15
195
1411
(3052851) Hemolysis interference index of Serum or Plasma
304
2306
1.33
5.32
3.1
3.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
252
1866
1.36
5.18
1.3
1.4
iu/ml
7.0
14.8
—
8
41
(3043409) Potassium [Moles/volume] in Arterial blood
290
2198
1.33
5.12
4.4
4.0
mmol/l
3.8
3.8
0.08
270
2066
(3012565) Volume of 24 hour Urine
62
338
1.84
4.93
2.7
2.2
ml
1932.2
1824.2
0.39
56
300
(36660697) Celiac disease serology panel - Serum
670
5637
1.20
4.88
1.2
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
519
4257
1.23
4.88
2.5
2.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
557
4604
1.22
4.86
1.3
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
375
2967
1.28
4.83
1.9
2.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1247
11053
1.15
4.80
2.0
2.0
s
29.5
29.6
0.15
1206
10702
(3009343) pH of Capillary blood
501
4102
1.24
4.79
3.3
3.4
ph
7.4
7.4
0.25
71
554
(3000570) Elastase.pancreatic [Mass/mass] in Stool
292
2241
1.31
4.75
1.4
1.4
ug/g
301.8
277.6
1.35
181
1310
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
375
2974
1.27
4.74
1.9
2.4
g/l
7.4
7.6
0.83
251
2190
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
506
4156
1.23
4.70
3.3
3.4
kpa
5.3
5.2
2.68
462
3817
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
996
8701
1.16
4.67
6.0
5.3
ug/l
3.5
3.9
0.17
886
7648
(3006184) Hemoglobin [Mass/volume] in Capillary blood
223
1650
1.36
4.65
2.2
2.2
g/l
128.3
125.5
0.90
164
1176
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
373
2966
1.27
4.62
1.9
2.4
g/l
3.8
3.8
0.11
242
2085
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
951
8286
1.17
4.61
1.8
1.7
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
46
233
1.98
4.57
1.3
1.7
ug/l
0.4
0.4
0.39
23
159
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
948
8266
1.17
4.56
1.8
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
281
2164
1.31
4.48
2.0
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
703
5995
1.19
4.43
4.7
4.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
247
1872
1.33
4.42
1.3
1.3
u/ml
4.2
6.0
0.81
46
327
(3033705) Calcium.ionized [Moles/volume] in Venous blood
137
945
1.46
4.30
2.8
2.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
780
6733
1.17
4.27
2.6
2.8
ng/l
177.2
195.5
0.77
718
6157
(3037121) Protein [Mass/volume] in Urine
315
2483
1.28
4.22
2.3
3.0
g/l
0.3
0.3
0.06
112
880
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
226
1705
1.33
4.19
1.2
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
357
2864
1.26
4.15
1.9
1.9
ug/l
2.3
2.5
0.08
318
2507
(3000991) Gas panel - Venous blood
678
5803
1.18
4.11
6.4
7.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
104
688
1.52
4.03
1.5
1.5
%
31.5
32.2
0.06
59
408
(3035285) Chloride [Moles/volume] in Venous blood
137
958
1.44
4.03
2.8
2.3
mmol/l
105.8
105.5
0.31
137
950
(3041354) Potassium [Moles/volume] in Venous blood
137
958
1.44
4.03
2.8
2.3
mmol/l
4.0
4.0
0.75
137
950
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
346
2782
1.25
3.96
1.9
2.4
g/l
3.1
3.1
0.04
242
2133
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
180
1325
1.37
3.94
2.2
1.9
u/l
5180.0
4133.8
0.17
64
521
(40768443) Skin Pathology biopsy report
418
3436
1.23
3.91
1.2
1.2
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
40
205
1.96
3.90
1.2
1.3
g/l
0.3
0.3
0.06
34
166
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
76
473
1.61
3.86
1.4
1.3
u/ml
1.2
1.0
0.07
39
237
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
798
6963
1.16
3.82
5.1
4.6
%
22.5
21.8
0.75
449
3628
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
239
1846
1.30
3.79
1.3
1.3
u/ml
7.6
5.6
0.12
27
209
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
345
2790
1.25
3.77
1.9
2.4
g/l
9.7
10.2
1.48
269
2304
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
251
1956
1.29
3.73
1.4
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
714
6202
1.16
3.64
5.2
6.0
mmol/l
1.3
1.3
1.06
686
5987
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
110
754
1.46
3.63
1.2
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
139
996
1.40
3.61
1.1
1.1
au/ml
8.1
16.6
—
7
39
(3037756) Immunofixation for Serum or Plasma
212
1624
1.31
3.59
1.5
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
72
452
1.60
3.56
1.8
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
169
1254
1.35
3.56
1.6
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
307
2471
1.25
3.52
3.1
3.4
mg/l
70.3
53.4
0.44
257
1964
(3003338) MCHC [Mass/volume]
6067
59064
1.09
3.43
22.4
19.3
g/l
330.6
330.7
0.04
6033
58606
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1317
11962
1.12
3.43
1.9
1.8
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
313
2536
1.24
3.40
2.1
2.5
g/l
1.0
1.0
0.01
258
2137
(3034891) Synovial lining cells/100 cells in Synovial fluid
59
357
1.66
3.39
1.4
1.4
%
1.2
4.2
2.65
13
68
(3038177) Helicobacter pylori Ab [Presence] in Serum
149
1094
1.37
3.37
1.2
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
36
188
1.92
3.37
11.1
11.1
mmol/l
0.7
0.6
1.61
30
167
(3022313) Gas panel - Capillary blood
354
2911
1.23
3.35
3.4
3.6
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
90
606
1.49
3.28
1.9
2.0
mg/l
3.9
3.9
0.07
90
575
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
304
2469
1.24
3.25
3.1
3.4
mg/l
31.9
45.2
2.32
253
1966
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
296
2405
1.24
3.16
3.0
3.3
ratio
6.8
4.5
0.17
28
172
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
271
2181
1.25
3.15
1.8
2.3
g/l
0.1
0.0
0.41
242
1977
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
288
2334
1.24
3.15
1.7
2.2
g/l
37.7
37.5
0.30
233
1967
(3000093) Morphology [Interpretation] in Blood Narrative
92
630
1.47
3.11
1.2
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
140
1034
1.36
3.09
1.4
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
279
2260
1.24
3.07
4.7
5.5
mmol/l
1.3
1.3
0.10
253
1992
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
103
727
1.42
2.98
1.0
1.0
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
5
5
10.00
2.98
6.8
1.0
mu/l
2.0
2.9
—
5
5
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
309
2543
1.22
2.95
3.5
3.7
mmol/l
25.3
25.1
0.94
282
2312
(46235355) HIV 1 and 2 tests - Meaningful Use set
923
8290
1.13
2.92
1.6
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
181
1403
1.30
2.89
1.7
1.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
106
757
1.41
2.89
1.2
1.4
nmol/l
0.3
0.4
1.00
70
549
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
15
58
2.59
2.87
2.0
1.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
228
1826
1.26
2.81
1.1
1.1
u/ml
7.8
9.7
0.14
29
165
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1536
14210
1.10
2.80
1.4
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
245
1981
1.24
2.78
1.1
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
985
8915
1.12
2.75
3.6
3.9
ug/l
8.0
24.4
3.02
802
7224
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
129
961
1.35
2.74
1.1
1.1
u/ml
0.9
0.9
0.03
51
345
(21494890) Protein electrophoresis panel - 24 hour Urine
105
757
1.39
2.73
1.9
2.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
32
174
1.84
2.71
1.1
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
296
2450
1.22
2.70
1.4
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
685
6076
1.14
2.67
2.4
2.5
e9/l
70.2
69.8
0.12
512
4549
(3001893) Eosinophils/100 leukocytes in Pleural fluid
39
227
1.72
2.65
1.2
1.4
%
2.5
2.6
0.04
34
188
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
283
2339
1.22
2.63
1.5
1.5
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
7
15
4.67
2.59
1.1
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
250
2044
1.23
2.58
1.7
2.4
g/l
0.0
0.0
0.78
221
1849
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
11
38
2.90
2.58
1.2
1.1
—
—
—
0
0
(4146454)
107
784
1.37
2.55
2.7
2.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
142
1086
1.31
2.55
1.3
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
464
4018
1.16
2.55
4.6
3.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
648
5747
1.14
2.54
1.7
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
232
1886
1.24
2.54
1.6
1.6
e6/l
10459.1
14014.8
0.81
166
1361
(3023511) Choriogonadotropin [Units/volume] in Urine
97
701
1.39
2.51
1.4
1.3
—
—
—
0
0
(3010421) pH of Blood
226
1837
1.24
2.48
4.2
3.7
ph
7.4
7.4
0.78
188
1554
(3003434) Protein [Mass/volume] in Pleural fluid
124
935
1.33
2.47
1.4
1.5
g/l
33.4
32.2
0.51
115
846
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
125
944
1.33
2.46
1.8
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
190
1517
1.26
2.45
4.1
3.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
222
1804
1.24
2.45
3.5
3.2
nmol/l
0.8
0.8
0.09
184
1411
(3047007) Chlamydophila sp Ab [Presence] in Serum
119
893
1.34
2.45
1.2
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
22
110
2.00
2.40
1.6
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
561
4949
1.14
2.40
3.4
3.2
ug/l
0.8
0.8
0.03
423
3512
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
245
2017
1.22
2.40
1.8
2.4
g/l
0.0
0.0
0.00
220
1843
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1023
9356
1.11
2.37
5.0
4.6
%
32.8
33.5
1.26
674
5942
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
245
2025
1.22
2.32
1.5
1.6
iu/ml
0.5
4.3
0.73
61
448
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
32
184
1.74
2.31
1.3
1.1
pmol/l
498.0
310.7
0.46
17
128
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
166
1316
1.27
2.29
1.3
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
126
964
1.31
2.29
1.3
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
156
1228
1.28
2.29
3.0
2.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
180
1442
1.25
2.28
2.9
2.8
kpa
8.1
8.0
0.37
171
1341
(3003327) Ova and parasites identified in Stool by Light microscopy
278
2330
1.20
2.28
1.7
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
153
1204
1.28
2.25
1.4
1.6
—
—
—
0
0
(3039000) Anion gap in Blood
200
1624
1.24
2.25
5.2
6.2
mmol/l
10.8
11.1
0.61
184
1448
(37021550) Renin [Units/volume] in Plasma --upright
28
156
1.80
2.24
1.3
1.2
mu/l
97.3
73.8
0.17
19
111
(3018572) Chloride [Moles/volume] in Blood
200
1625
1.24
2.24
5.2
6.2
mmol/l
105.0
104.9
0.08
184
1449
(3027315) Oxygen [Partial pressure] in Blood
197
1598
1.24
2.24
4.4
3.8
kpa
8.7
8.5
0.58
190
1568
(40760888) Immunoglobulin light chains.free panel - Serum
225
1852
1.22
2.23
3.5
3.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
198
1608
1.24
2.23
3.9
3.6
mg/l
22.7
26.8
1.06
129
1003
(3017143) Hepatitis C virus Ab [Presence] in Serum
700
6294
1.12
2.23
1.6
1.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
195
1583
1.24
2.21
4.4
3.8
mmol/l
2.9
2.7
0.45
138
1131
(40768800) Prostate Pathology biopsy report
80
574
1.40
2.21
1.2
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
207
1692
1.23
2.20
2.9
2.9
mmol/l
25.5
25.1
0.72
185
1481
(3020491) Glucose [Moles/volume] in Blood
67
466
1.44
2.19
1.7
2.2
mmol/l
7.2
6.9
0.36
53
320
(3020779) Urea [Moles/volume] in Serum or Plasma
645
5778
1.13
2.19
7.4
6.3
mmol/l
10.4
9.9
1.05
613
5476
(3013290) Carbon dioxide [Partial pressure] in Blood
195
1585
1.24
2.19
4.4
3.8
kpa
5.0
5.0
0.08
188
1556
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
12
48
2.50
2.18
1.8
1.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
126
972
1.30
2.17
3.1
2.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
153
1211
1.27
2.16
1.4
1.4
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
108
816
1.33
2.16
1.0
1.1
u/ml
1.7
3.4
1.32
41
317
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
63
436
1.45
2.13
1.1
1.1
iu/ml
4.4
10.7
2.15
11
94
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
468
4116
1.14
2.13
5.0
6.2
mmol/l
25.5
25.0
2.01
461
4085
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
192
1565
1.23
2.11
1.3
1.2
u/ml
8.1
4.3
0.31
24
111
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
15
68
2.21
2.10
1.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
116
890
1.31
2.10
1.4
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
190
1552
1.23
2.05
1.3
1.3
miu/ml
234.1
222.6
0.14
69
708
(3033923) Metanephrine [Moles/time] in 24 hour Urine
32
191
1.68
2.05
1.0
1.1
umol/24h
1.2
0.6
0.43
13
86
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
42
269
1.56
2.05
3.0
2.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
283
2404
1.18
2.03
1.7
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
117
904
1.30
2.02
1.4
1.4
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
10
38
2.63
2.00
1.2
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
94
707
1.33
1.97
1.3
1.4
e6/l
162939.4
123924.8
0.17
56
479
(3017704) Immunofixation for Urine
58
402
1.45
1.97
1.7
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
194
1598
1.22
1.95
1.4
1.5
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
41
265
1.55
1.94
1.2
1.4
%
64.0
64.5
0.03
34
214
(3045414) Leukocytes [Presence] in Urine
396
3470
1.15
1.93
1.9
1.9
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
417
3671
1.14
1.90
6.8
8.0
mmol/l
25.0
24.5
2.81
383
3424
(3004775) Volume in Urine collected for unspecified duration
70
506
1.39
1.90
2.1
2.3
ml
712.2
650.5
0.61
45
344
(3039162) Centromere protein B Ab [Units/volume] in Serum
121
950
1.28
1.87
1.2
1.2
u/ml
22.8
55.2
1.78
12
80
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
128
1013
1.27
1.86
1.3
1.2
u/l
28.6
40.0
0.82
108
863
(3004451) EKG impression Narrative
53
367
1.45
1.83
1.2
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
52
359
1.45
1.82
2.1
1.6
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
5
12
4.17
1.82
1.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
7
23
3.05
1.79
1.0
1.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
146
1180
1.24
1.79
1.4
1.6
nmol/l
0.8
0.8
0.54
126
981
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
225
1902
1.19
1.76
1.6
1.6
—
—
—
0
0
(3014891) Appearance of Pleural fluid
19
102
1.86
1.75
1.7
1.5
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
21
117
1.80
1.73
1.1
1.4
%
7.2
13.0
0.95
11
62
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
9
36
2.50
1.73
1.2
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
241
2052
1.18
1.73
1.9
1.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
36
233
1.55
1.72
1.1
1.1
miu/ml
1523.1
1514.7
0.02
36
233
(3043410) Blood group antigens tested for on Red Blood Cells
30
186
1.62
1.71
2.6
1.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
563
5093
1.11
1.67
2.8
2.9
g/l
10.1
10.4
0.86
516
4678
(3003888) Timothy IgE Ab [Units/volume] in Serum
110
869
1.27
1.66
1.1
1.1
u/ml
3.5
3.7
0.06
59
400
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
115
916
1.26
1.63
6.2
6.1
mg/l
11.8
12.4
0.84
97
831
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
112
891
1.26
1.60
1.1
1.1
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
8
32
2.50
1.59
1.1
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
14
70
2.00
1.59
1.7
2.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
195
1648
1.19
1.56
1.4
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
114
913
1.25
1.55
3.1
2.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
86
665
1.30
1.55
2.3
2.2
u/field
2.6
2.7
0.06
33
250
(3025018) Bordetella pertussis Ab [Titer] in Serum
54
389
1.39
1.55
1.3
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
196
1659
1.19
1.55
1.3
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
150
1240
1.21
1.53
1.4
1.4
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
36
241
1.50
1.51
3.8
2.8
umol/l
27.4
28.0
0.15
30
175
(3014765) Yersinia sp identified in Stool by Organism specific culture
257
2231
1.16
1.49
1.2
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
97
767
1.27
1.48
1.2
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
90
705
1.28
1.48
1.5
1.4
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
53
384
1.38
1.48
1.0
1.1
nmol/l
2.4
9.5
0.91
14
79
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
74
565
1.31
1.48
1.6
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
179
1512
1.19
1.46
2.9
2.4
%
16.1
15.8
0.42
98
753
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
55
402
1.37
1.46
1.2
1.6
u/l
8.2
5.5
0.41
42
333
(3003694) ABO and Rh group [Type] in Blood
1884
17999
1.06
1.46
1.4
1.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
102
815
1.25
1.44
1.3
1.2
mmol/l
7.0
7.5
1.12
81
586
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
5
16
3.13
1.44
1.4
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
6
22
2.73
1.43
1.0
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
257
2240
1.15
1.43
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
253
2203
1.15
1.42
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
116
942
1.23
1.42
1.0
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
444
4013
1.11
1.39
2.0
2.0
g/l
1.3
1.4
0.39
402
3641
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
13
67
1.94
1.38
1.2
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
13
67
1.94
1.38
1.8
2.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
366
3274
1.12
1.38
1.6
1.6
g/l
1.6
1.6
0.40
311
2793
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
67
511
1.31
1.37
1.1
1.2
titre
227.0
164.1
—
10
91
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
759
7043
1.09
1.37
1.9
2.1
g/l
0.2
0.2
2.39
711
6567
(3045683) HLA typing for celiac disease panel - Blood or Tissue
49
356
1.38
1.37
1.0
1.0
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
84
661
1.27
1.36
1.5
1.4
g/l
0.4
0.4
0.34
61
455
(3027135) IgG subclass 1 [Mass/volume] in Serum
84
661
1.27
1.36
1.5
1.4
g/l
6.7
6.8
0.10
61
454
(4062490)
84
662
1.27
1.35
1.5
1.4
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
84
662
1.27
1.35
1.5
1.4
g/l
2.7
2.8
0.19
62
459
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
8
164
0.49
1.35
3.3
2.4
nmol/l
145.1
160.4
—
8
134
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
31
207
1.50
1.34
1.3
1.4
%
31.8
34.2
0.15
20
137
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
168
1426
1.18
1.33
1.6
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
114
933
1.22
1.32
1.1
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
22
136
1.62
1.32
1.1
1.4
umol/l
15.6
17.5
1.52
17
125
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
327
2915
1.13
1.32
2.8
3.3
u/ml
357.2
2765.4
1.62
272
2442
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
6
24
2.50
1.30
1.0
1.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
9
43
2.09
1.30
6.3
4.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
102
827
1.24
1.30
1.4
1.4
e6/l
2535.8
2914.5
0.13
79
601
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
55
412
1.34
1.28
1.1
1.1
u/l
16.5
26.5
1.88
41
313
(3026692) Albumin [Mass/volume] in Peritoneal fluid
9
173
0.52
1.28
1.1
1.4
g/l
16.1
14.0
—
9
137
(4015189)
28
185
1.52
1.28
2.0
2.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
88
703
1.25
1.28
3.3
3.7
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
167
1423
1.18
1.27
1.3
1.4
e6/l
37.9
34.2
0.04
127
1100
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
55
413
1.33
1.27
1.1
1.1
u/l
79.2
86.0
0.50
45
318
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
167
1424
1.18
1.26
1.3
1.5
e6/l
772.2
1236.7
0.45
135
1157
(3014148) Varicella zoster virus Ab [Titer] in Serum
79
624
1.27
1.26
1.1
1.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
12
217
0.55
1.26
1.1
1.5
—
712172.2
—
0
9
(3048929) Epstein Barr virus Ab [Presence] in Serum
174
1490
1.17
1.25
1.1
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
270
2388
1.13
1.25
2.4
2.9
u/ml
0.3
0.4
0.64
161
1371
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
24
155
1.55
1.22
1.4
1.4
ng/l
75.8
103.4
1.16
24
155
(3041806) Other cells [#/volume] in Blood by Manual count
11
56
1.97
1.22
1.7
1.6
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
5
19
2.63
1.21
1.0
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
14
78
1.80
1.20
17.8
11.7
mmol/l
4.8
5.0
0.15
14
78
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
14
78
1.80
1.20
1.1
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
215
1879
1.15
1.20
1.2
1.2
titre
586.0
840.4
—
10
69
(3004809) Band form neutrophils/100 leukocytes in Blood
139
1174
1.19
1.19
3.0
3.3
%
1.6
1.3
0.32
112
901
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
188
1628
1.16
1.19
1.3
1.4
mg/l
485.3
521.4
0.59
180
1534
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
800
7488
1.08
1.18
1.6
1.5
—
—
—
0
0
(44813793)
64
497
1.29
1.18
1.2
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
102
837
1.22
1.18
1.1
1.1
u/ml
0.9
1.0
0.08
46
317
(3004716) Salmonella sp identified in Stool by Organism specific culture
372
3369
1.11
1.17
1.3
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
65
509
1.28
1.14
1.6
1.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
212
1862
1.14
1.12
1.2
1.2
titre
75.0
142.1
1.06
12
157
(3024980) IgG subclass 4 [Mass/volume] in Serum
122
1026
1.19
1.12
1.6
1.5
g/l
0.7
0.7
0.04
92
759
(3044290) Cell count panel - Cerebral spinal fluid
154
1322
1.17
1.11
1.2
1.4
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
10
51
1.96
1.11
1.2
1.6
%
23.8
42.3
—
5
36
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
48
362
1.33
1.11
1.3
1.2
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
7
31
2.26
1.10
1.4
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
260
2317
1.13
1.10
1.5
1.4
pmol/l
133.8
176.7
1.05
254
2253
(3006270) Folate [Moles/volume] in Blood
76
611
1.25
1.08
1.2
1.2
nmol/l
351.2
350.3
0.01
64
509
(3036525) Urea [Moles/time] in 24 hour Urine
7
32
2.19
1.08
5.4
3.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
82
667
1.23
1.06
1.0
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
24
161
1.49
1.06
1.2
1.3
nmol/l
151.7
112.3
0.32
13
110
(3051611) Lipemic interference index of Serum or Plasma
100
832
1.20
1.04
2.5
3.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
73
588
1.24
1.04
1.1
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
255
2282
1.12
1.02
1.3
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
88
725
1.22
1.02
1.3
1.5
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
9
47
1.92
1.02
1.7
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
47
359
1.31
1.01
2.7
3.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
37
273
1.36
1.00
1.1
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
56
439
1.28
1.00
1.3
1.7
ug/l
2.3
5.1
1.31
38
328
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
62
494
1.26
0.98
1.3
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
90
748
1.21
0.97
1.0
1.1
u/ml
0.2
1.8
3.47
19
166
(3034274) Bile acid [Moles/volume] in Serum --fasting
63
504
1.25
0.96
1.5
1.8
umol/l
7.2
8.7
0.26
42
358
(3035880) pH of Pleural fluid
48
371
1.30
0.96
1.1
1.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
162
1416
1.15
0.95
1.2
1.3
mmol/l
3.8
3.7
0.51
152
1324
(3020618) Glucose [Moles/volume] in Synovial fluid
0
32
0.00
0.95
0.0
1.0
—
5.0
—
0
20
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
30
216
1.39
0.95
1.1
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
99
833
1.19
0.94
1.1
1.1
g/l
1.5
1.5
1.30
93
751
(3017509) Phencyclidine [Presence] in Urine
7
37
1.89
0.94
1.0
1.3
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
7
37
1.89
0.94
1.0
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
140
1213
1.16
0.94
1.5
1.6
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
6
27
2.22
0.93
1.5
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
347
3177
1.10
0.93
3.5
3.9
mmol/l
24.8
24.4
1.21
305
2854
(43055514) Macroprolactin [Presence] in Serum or Plasma
13
78
1.67
0.91
1.7
1.5
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
182
1611
1.13
0.90
3.1
2.9
mg/l
1.7
1.6
0.85
161
1452
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
65
527
1.24
0.90
1.2
1.2
titre
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
25
176
1.42
0.90
1.0
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
361
3317
1.09
0.90
1.4
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
438
4060
1.08
0.89
1.4
1.3
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
64
520
1.23
0.88
1.3
1.3
nmol/l
1.3
1.4
0.37
56
478
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
75
620
1.21
0.87
1.4
1.6
u/ml
23.5
23.0
0.03
14
125
(3016750) Collection duration of Urine
47
369
1.28
0.86
2.1
2.1
min
488.2
504.5
0.70
37
279
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
488
4554
1.08
0.85
1.6
1.7
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
6
31
1.94
0.84
1.2
1.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
6
31
1.94
0.84
1.0
1.1
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
59
478
1.24
0.84
1.2
1.3
u/l
11.2
12.8
0.54
53
435
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
8
45
1.78
0.84
1.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
36
274
1.32
0.83
1.3
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
186
1660
1.12
0.83
1.1
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
79
661
1.20
0.83
1.2
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
385
3565
1.08
0.82
1.7
1.7
—
—
—
0
0
(3048879) Bone marrow aspiration report
13
202
0.64
0.82
1.2
1.8
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
66
543
1.22
0.82
1.2
1.2
u/ml
28.8
5.5
—
6
37
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
109
939
1.16
0.82
1.6
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
59
480
1.23
0.81
1.1
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
100
856
1.17
0.81
1.4
1.5
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
8
48
1.67
0.78
1.1
1.1
u/l
12.5
9.7
—
8
48
(3041672) Baker's yeast Ab [Presence] in Serum
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
27
199
1.36
0.78
1.1
1.2
%
109.2
93.0
1.56
16
91
(4268621)
73
611
1.20
0.77
2.1
2.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
17
246
0.69
0.77
1.2
1.2
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
237
2155
1.10
0.77
1.6
1.6
mg/l
2.8
3.3
0.62
179
1530
(3028433) Virus identified in Specimen by Culture
31
234
1.33
0.77
1.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
58
476
1.22
0.75
1.1
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
12
75
1.60
0.74
1.2
1.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
5
24
2.08
0.74
1.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
77
652
1.18
0.73
1.5
1.5
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
40
316
1.27
0.73
1.1
1.1
u/l
1.1
1.1
0.07
17
145
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
7
39
1.80
0.72
1.0
1.0
mmol/l
8.7
8.1
—
7
39
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
72
607
1.19
0.72
1.2
1.2
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
9
56
1.61
0.72
1.0
1.1
—
2.9
—
0
9
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
27
202
1.34
0.72
1.1
1.1
%
124.9
112.0
0.86
22
180
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
27
202
1.34
0.72
1.1
1.1
%
98.6
91.0
0.70
16
87
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
70
589
1.19
0.72
1.1
1.1
—
—
—
0
0
(44806071)
12
76
1.58
0.71
1.2
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
12
76
1.58
0.71
1.7
1.7
umol/l
19.5
18.0
0.14
12
76
(3000034) Microalbumin [Mass/volume] in Urine
77
654
1.18
0.71
2.7
2.7
mg/l
32.9
30.9
0.03
53
452
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
71
599
1.19
0.71
1.2
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
71
599
1.19
0.71
1.2
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
71
599
1.19
0.71
1.2
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
115
1009
1.14
0.70
1.3
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
38
300
1.27
0.70
1.1
1.2
nmol/l
131.1
136.4
0.41
38
300
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
68
573
1.19
0.69
1.2
1.2
u/ml
112.4
79.4
—
5
30
(3028308) Erythrocytes [#/volume] in Pleural fluid
87
749
1.16
0.69
1.4
1.4
e6/l
23667.4
55362.1
1.48
51
443
(40768806) Pleura Pathology biopsy report
86
740
1.16
0.69
1.6
1.5
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
19
135
1.41
0.68
1.1
1.1
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
12
77
1.56
0.68
1.2
1.1
u/ml
0.0
0.4
—
6
47
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
7
42
1.67
0.68
1.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
28
213
1.32
0.68
1.8
2.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
28
213
1.32
0.68
1.8
2.9
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
40
320
1.25
0.67
1.8
2.0
%
113.3
98.4
1.67
34
293
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
78
907
0.86
0.66
1.1
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
79
679
1.16
0.65
1.3
1.5
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
27
206
1.31
0.65
7.5
5.3
mmol/l
24.5
25.2
0.45
22
189
(3036048) Francisella tularensis Ab [Titer] in Serum
17
120
1.42
0.64
1.3
1.2
—
1680.0
—
0
7
(3024928) Oxygen saturation in Venous blood
157
1415
1.11
0.64
2.2
3.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
27
349
0.77
0.64
1.1
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
44
536
0.82
0.63
1.5
1.7
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
34
426
0.80
0.63
2.0
2.4
e6/l
414.0
502.6
0.61
28
350
(3023410) Appearance of Cerebral spinal fluid
75
644
1.17
0.63
1.4
1.6
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
18
129
1.40
0.63
1.1
1.2
mmol/l
1.4
1.8
—
9
76
(3012441) Differential panel - Pleural fluid
82
710
1.16
0.62
1.5
1.5
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
12
79
1.52
0.62
6.2
5.6
ug/min
38.7
43.7
0.14
12
59
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
121
1077
1.13
0.62
1.1
1.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
34
270
1.26
0.62
1.6
2.0
ug/l
20.2
186.7
0.91
34
251
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
51
424
1.20
0.62
2.0
2.0
u/field
1.8
2.8
0.63
35
283
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
11
71
1.55
0.62
1.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
16
113
1.42
0.61
1.0
1.0
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
16
113
1.42
0.61
1.3
1.4
pmol/l
64.2
55.7
—
5
39
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
183
1669
1.10
0.60
3.5
3.2
u/ml
228.9
500.9
0.77
167
1512
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
41
334
1.23
0.60
5.5
3.9
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
72
619
1.16
0.60
1.1
1.1
u/ml
1.3
2.9
1.63
26
228
(40758358) Immune stain study
8
51
1.57
0.60
1.0
1.0
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
99
872
1.14
0.60
1.2
1.2
u/l
64.9
58.9
0.32
64
581
(3000764) Benzodiazepines [Presence] in Urine
124
1108
1.12
0.60
1.3
1.6
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
9
141
0.64
0.60
1.1
1.8
—
—
—
0
0
(3007733) Chloride [Moles/volume] in Urine
0
22
0.00
0.59
0.0
1.1
—
80.4
—
0
17
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
176
1606
1.10
0.58
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
176
1606
1.10
0.58
1.3
1.3
—
—
—
0
0
(3013862) HLA-DP [Type]
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
22
166
1.33
0.58
1.3
1.4
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
13
89
1.46
0.57
1.1
1.1
umol/24h
1.9
1.6
0.78
13
89
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
189
1735
1.09
0.56
1.6
1.7
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
87
0.57
0.56
1.2
1.4
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
24
185
1.30
0.56
1.9
3.7
ng/l
88.0
133.8
—
10
61
(3014271) Vancomycin [Susceptibility]
36
440
0.82
0.55
3.1
3.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
10
65
1.54
0.55
4.8
4.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
41
339
1.21
0.54
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
124
1118
1.11
0.53
1.3
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
41
340
1.21
0.53
1.1
1.1
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
15
108
1.39
0.53
1.1
1.2
mmol/l
1.8
1.3
—
9
68
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
429
4069
1.06
0.53
1.8
1.8
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
38
313
1.21
0.53
3.6
2.5
mmol/l
9.3
9.1
0.12
22
247
(3037556) Urate [Mass/volume] in Serum or Plasma
24
187
1.28
0.52
1.8
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
122
1102
1.11
0.51
1.3
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
160
1466
1.09
0.51
1.3
1.4
mmol/l
60.0
61.3
0.18
124
1163
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
87
771
1.13
0.51
1.6
1.6
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
112
1008
1.11
0.51
1.3
1.3
u/ml
109.7
120.5
0.65
25
221
(3027008) Opiates [Presence] in Urine
123
1113
1.11
0.50
1.3
1.6
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
25
197
1.27
0.50
1.3
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
26
206
1.26
0.50
1.5
1.4
—
—
—
0
0
(4034850)
262
2451
1.07
0.50
9.6
9.9
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
10
145
0.69
0.50
1.7
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
11
156
0.70
0.49
1.3
2.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
39
325
1.20
0.49
2.3
2.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
121
1097
1.10
0.49
1.2
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
7
108
0.65
0.48
1.4
1.7
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
112
1012
1.11
0.48
2.4
2.1
mg/l
22.3
24.3
0.21
38
252
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
55
636
0.86
0.48
1.1
1.1
%
95.3
94.5
0.09
47
594
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
29
235
1.23
0.48
2.3
2.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
50
428
1.17
0.48
2.3
3.6
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
30
366
0.82
0.47
3.1
2.7
%
42.6
39.9
—
7
131
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
104
938
1.11
0.47
1.3
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
421
4419
0.95
0.47
1.3
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
11
154
0.71
0.46
1.0
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
31
254
1.22
0.46
1.4
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
51
439
1.16
0.46
1.6
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
32
385
0.83
0.45
2.6
3.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
78
875
0.89
0.45
1.0
1.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
21
165
1.27
0.44
1.4
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
112
1018
1.10
0.44
1.2
1.2
u/ml
303.3
290.6
0.12
68
613
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
60
525
1.14
0.44
1.4
1.5
u/l
5.8
6.4
0.13
27
253
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
60
525
1.14
0.44
1.1
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
12
86
1.40
0.44
1.2
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
30
247
1.22
0.44
1.3
1.3
g/l
38.9
39.5
0.10
14
132
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
13
95
1.37
0.43
1.0
1.1
u/ml
41.0
53.0
0.59
13
89
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
9
130
0.69
0.43
1.1
1.2
%
141.7
112.5
—
9
121
(3014133) Dog dander IgE Ab [Units/volume] in Serum
74
659
1.12
0.42
1.1
1.0
u/ml
0.9
3.1
2.83
25
233
(3040151) Glucose [Moles/volume] in Capillary blood
88
792
1.11
0.42
4.0
5.2
mmol/l
7.1
7.3
0.11
73
655
(40768795) Lymph node Pathology biopsy report
93
841
1.11
0.41
1.2
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
10
70
1.43
0.41
1.1
1.1
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
5
33
1.52
0.41
1.2
1.6
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
56
491
1.14
0.41
2.5
2.1
ug/l
3.4
2.5
0.62
51
423
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.2
—
1.8
—
0
15
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
106
966
1.10
0.41
1.3
1.4
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
29
240
1.21
0.41
1.3
3.1
mg/l
53.6
966.3
0.50
18
161
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
12
161
0.74
0.41
1.2
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
202
1894
1.07
0.40
2.4
2.4
g/l
3.7
3.6
0.18
194
1783
(3020650) Glucose [Presence] in Urine
21
168
1.25
0.40
1.4
1.4
—
—
—
0
0
(44790047)
83
749
1.11
0.39
1.4
1.4
—
—
—
0
0
(44790048)
83
749
1.11
0.39
1.4
1.4
—
—
—
0
0
(44790049)
83
749
1.11
0.39
1.4
1.4
—
—
—
0
0
(44806118)
83
749
1.11
0.39
1.4
1.4
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
25
205
1.22
0.39
1.8
1.5
mmol/l
8.1
8.4
0.19
14
116
(3013762) Body weight Measured
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
102
932
1.10
0.38
1.3
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
102
932
1.10
0.38
1.3
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
66
738
0.89
0.38
1.5
1.5
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
36
1.39
0.38
1.0
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
15
192
0.78
0.37
1.2
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
55
486
1.13
0.37
1.2
1.3
mmol/l
12.4
11.7
0.14
14
130
(3026470) Cobalt [Mass/volume] in Blood
57
505
1.13
0.37
2.3
2.0
ug/l
6.7
3.5
0.87
52
449
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
72
1.39
0.36
1.0
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
34
290
1.17
0.36
1.2
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
77
850
0.91
0.36
1.4
1.4
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
10
135
0.74
0.36
1.2
1.4
g/l
32.6
26.4
—
10
117
(3016650) Hepatitis A virus Ab [Presence] in Serum
107
984
1.09
0.36
1.1
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
11
146
0.75
0.36
1.2
2.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
325
3105
1.05
0.35
1.5
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
46
523
0.88
0.35
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
49
432
1.14
0.35
1.1
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
11
145
0.76
0.34
1.2
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
84
766
1.10
0.34
3.4
3.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
118
1093
1.08
0.34
1.7
1.6
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
12
156
0.77
0.34
1.5
2.1
e6/l
1051.4
451.5
—
7
80
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
39
339
1.15
0.34
1.4
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
44
386
1.14
0.34
1.7
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
33
283
1.17
0.34
1.2
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
33
283
1.17
0.34
1.2
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
121
1123
1.08
0.34
1.4
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
38
330
1.15
0.33
1.7
1.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
29
340
0.85
0.33
2.8
2.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
56
500
1.12
0.33
1.5
2.1
%
10.4
10.5
0.08
56
500
(3042733) HLA Ab [Presence] in Serum
16
127
1.26
0.33
5.6
4.9
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
14
109
1.28
0.33
1.4
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
44
387
1.14
0.33
1.0
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
155
0.77
0.33
1.2
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
22
264
0.83
0.33
1.4
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
22
182
1.21
0.33
1.2
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
583
6010
0.97
0.32
1.6
1.6
%
1.4
1.4
1.87
503
5166
(3017354) Segmented neutrophils/100 leukocytes in Blood
78
713
1.09
0.31
2.8
3.5
%
60.9
58.1
0.51
51
447
(3032057) Clostridioides difficile [Presence] in Stool
21
174
1.21
0.31
1.3
1.8
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
39
342
1.14
0.31
1.0
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
7
52
1.35
0.31
1.1
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
11
142
0.77
0.30
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
44
390
1.13
0.30
1.0
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
90
830
1.09
0.30
1.1
1.1
iu/ml
20.1
13567.5
0.57
13
181
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
37
324
1.14
0.30
1.2
1.1
—
—
—
0
0
(4212803)
10
75
1.33
0.30
1.0
1.1
—
—
—
0
0
(4306422)
83
901
0.92
0.30
1.2
1.2
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
21
250
0.84
0.30
1.5
2.0
e6/l
6518.6
2813.6
0.25
12
171
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
20
166
1.21
0.29
1.1
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
43
382
1.13
0.29
1.7
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
102
948
1.08
0.29
1.3
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
35
307
1.14
0.28
1.2
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
16
130
1.23
0.28
4.6
2.8
—
—
—
0
0
(4024509)
91
843
1.08
0.28
1.5
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
68
622
1.09
0.28
1.3
1.5
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
10
76
1.32
0.28
1.5
1.5
umol/l
53.1
43.1
—
10
76
(3019230) Fractional oxyhemoglobin in Venous blood
122
1145
1.07
0.27
2.2
2.8
%
61.8
62.2
0.08
122
1139
(3025468) Yersinia sp identified in Specimen by Organism specific culture
100
932
1.07
0.27
1.3
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
100
1072
0.93
0.27
1.4
1.7
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
9
118
0.76
0.27
1.3
1.5
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
16
131
1.22
0.27
4.9
7.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
20
168
1.19
0.27
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
80
740
1.08
0.26
1.4
2.2
—
—
—
0
0
(4211845)
37
416
0.89
0.26
2.4
3.5
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
18
214
0.84
0.26
1.4
1.8
e6/l
9193.0
20060.5
—
8
116
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
74
0.68
0.26
3.2
6.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
45
405
1.11
0.26
1.0
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
43
386
1.11
0.26
1.3
1.1
ratio
1.1
1.1
0.49
12
134
(40757373) Influenza virus identified in Isolate
12
149
0.81
0.25
1.8
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
40
446
0.90
0.25
1.5
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
309
2981
1.04
0.25
1.3
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
170
1618
1.05
0.25
1.4
1.3
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
15
181
0.83
0.25
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
15
181
0.83
0.25
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
15
181
0.83
0.25
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
15
181
0.83
0.25
1.0
1.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
24
277
0.87
0.25
2.0
2.2
umol/l
61.3
54.8
0.36
17
222
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
194
1854
1.05
0.24
2.0
2.2
%
180.7
197.6
2.33
178
1751
(3020393) Adenovirus Ag [Presence] in Stool
9
76
1.18
0.24
1.0
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
76
1.18
0.24
1.2
1.1
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
12
96
1.25
0.24
1.1
1.3
u/l
33.4
364.5
—
7
68
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
11
87
1.26
0.24
3.3
2.7
—
34.8
—
0
12
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
71
657
1.08
0.24
1.4
1.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
24
276
0.87
0.24
1.0
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
15
180
0.83
0.24
2.7
2.9
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
15
124
1.21
0.23
1.8
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
27
307
0.88
0.23
1.7
1.8
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
81
868
0.93
0.23
1.1
1.1
%
127.9
120.2
1.36
67
768
(3020191) Ethanol [Moles/volume] in Serum or Plasma
43
389
1.11
0.23
1.7
1.5
promille
0.9
1.1
0.48
33
291
(3043238) Trisomy 21 risk [Likelihood] in Fetus
55
599
0.92
0.23
1.5
1.5
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
13
106
1.23
0.23
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
49
536
0.91
0.23
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
49
536
0.91
0.23
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
49
536
0.91
0.23
1.1
1.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
104
980
1.06
0.22
2.4
2.3
u/ml
872.4
1869.7
—
7
63
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
11
88
1.25
0.22
1.2
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
11
88
1.25
0.22
1.0
1.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
18
153
1.18
0.22
1.1
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
95
0.74
0.22
2.3
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
31
276
1.12
0.22
2.2
2.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
22
191
1.15
0.21
1.7
1.5
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
34
305
1.12
0.21
1.1
1.0
u/ml
0.5
1.6
0.64
14
96
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
30
336
0.89
0.21
1.0
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
175
1826
0.96
0.21
2.3
2.2
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
11
0.00
0.21
0.0
1.1
—
3356.1
—
0
11
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
5.2
—
0.2
—
0
11
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036489) Thrombin time
245
2538
0.96
0.21
1.6
1.9
s
21.4
21.6
0.21
217
2210
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
13
156
0.83
0.21
1.0
1.2
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
5
43
1.16
0.21
1.2
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
36
325
1.11
0.21
1.1
1.1
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
39
354
1.10
0.20
1.2
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
11
134
0.82
0.20
1.1
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
17
198
0.86
0.20
1.2
1.1
—
—
—
0
0
(4281824)
112
1180
0.95
0.20
1.1
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
38
418
0.91
0.20
2.5
2.5
e6/l
569.5
716.0
0.77
14
170
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
164
1.16
0.20
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
13
155
0.84
0.20
1.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
18
155
1.16
0.19
1.2
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
249
2410
1.03
0.19
1.8
2.2
ug/l
389.7
597.6
0.80
224
2252
(3025315) Body weight
6
51
1.18
0.19
4.0
4.5
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
20
228
0.88
0.19
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
48
519
0.92
0.18
1.2
1.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
193
2000
0.96
0.18
1.7
2.0
%
95.5
92.5
1.11
178
1860
(3002523) Influenza virus A Ag [Presence] in Specimen
78
735
1.06
0.18
1.0
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
41
446
0.92
0.18
1.2
1.1
mg/l
46.9
38.8
0.40
36
378
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
50
539
0.93
0.18
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
50
539
0.93
0.18
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
50
539
0.93
0.18
1.1
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
15
128
1.17
0.18
1.1
1.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
27
242
1.12
0.18
1.1
1.1
ng/l
459.2
682.9
—
6
57
(3033799) Differential panel - Peritoneal fluid
18
206
0.87
0.18
1.4
1.8
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
12
100
1.20
0.18
1.1
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
48
518
0.93
0.18
1.3
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
34
373
0.91
0.18
1.3
1.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
78
736
1.06
0.18
1.0
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
7
60
1.17
0.17
1.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
38
348
1.09
0.17
1.3
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
38
348
1.09
0.17
1.3
1.3
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
11
91
1.21
0.17
1.0
1.1
ug/l
83.3
75.5
0.24
11
72
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
52
484
1.07
0.17
2.0
1.8
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
7
62
1.13
0.17
1.3
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
46
426
1.08
0.17
1.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
54
578
0.93
0.17
1.4
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
192
1858
1.03
0.16
1.9
1.8
—
—
—
0
0
(3000012) Reticulocyte production index
44
408
1.08
0.16
1.6
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
54
576
0.94
0.16
1.4
1.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
79
1.14
0.15
1.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
9
80
1.13
0.15
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
9
80
1.13
0.15
1.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
9
80
1.13
0.15
1.0
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
69
654
1.06
0.14
2.9
2.7
—
—
—
0
0
(3024932) HLA-DR beta [Type]
13
150
0.87
0.14
1.0
1.1
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
22
244
0.90
0.14
11.4
10.4
nmol/l
823.6
871.8
0.15
22
232
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
7
87
0.80
0.14
1.1
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
126
1308
0.96
0.14
1.4
1.5
—
—
—
0
0
(4198724)
15
131
1.15
0.14
1.3
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
38
353
1.08
0.14
1.2
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
38
353
1.08
0.14
1.2
1.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
38
353
1.08
0.14
1.7
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
38
353
1.08
0.14
1.2
1.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
22
243
0.91
0.13
1.0
1.1
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
14
122
1.15
0.13
3.9
3.1
u/l
1677.1
2327.6
0.18
14
116
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
27
247
1.09
0.13
2.3
2.6
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
26
284
0.92
0.13
1.7
1.9
umol/l
132.1
116.3
0.11
14
165
(3029075) Extractable nuclear Ab panel - Serum
16
180
0.89
0.13
1.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
286
2798
1.02
0.13
1.7
1.8
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
13
113
1.15
0.13
1.3
2.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
117
0.85
0.13
1.0
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
28
304
0.92
0.13
1.1
1.0
u/ml
0.5
0.5
—
8
78
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
26
238
1.09
0.13
1.1
1.1
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
18
161
1.12
0.13
1.0
1.2
mg/l
0.8
30.5
0.50
13
118
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
48
509
0.94
0.12
1.3
1.4
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
48
509
0.94
0.12
1.0
1.0
ng/l
45.0
46.0
0.04
30
347
(3012494) Peanut IgE Ab [Units/volume] in Serum
15
169
0.89
0.12
1.0
1.1
u/ml
0.5
1.2
—
8
85
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
14
123
1.14
0.12
2.6
5.5
u/l
40.0
41.6
—
5
43
(3051593) INR in Capillary blood by Coagulation assay
39
365
1.07
0.12
3.1
13.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
66
691
0.95
0.11
1.4
1.4
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
48
507
0.95
0.11
1.0
1.0
ng/l
662.0
696.6
0.32
26
340
(3003129) Base excess in Capillary blood by calculation
19
172
1.10
0.11
1.5
1.8
mmol/l
0.8
0.6
0.12
19
160
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
66
690
0.96
0.11
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
66
690
0.96
0.11
1.4
1.4
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
12
105
1.14
0.11
1.9
3.1
u/field
1.2
0.8
0.46
12
105
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
12
136
0.88
0.11
1.2
1.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
66
689
0.96
0.10
1.4
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
60
627
0.96
0.10
2.2
2.3
e9/l
1.3
1.1
0.66
41
397
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
46
484
0.95
0.10
2.1
2.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
24
259
0.93
0.10
2.5
2.5
—
38.4
—
0
5
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
5
44
1.14
0.10
1.2
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
5
47
1.06
0.09
1.2
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
48
1.04
0.09
1.4
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
98
951
1.03
0.09
1.3
1.2
u/ml
2.9
3.6
0.19
31
295
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
21
194
1.08
0.09
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
94
912
1.03
0.09
1.3
1.2
u/ml
6.8
3.9
0.50
37
372
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
129
1259
1.02
0.08
5.2
4.7
iu/ml
796.2
2208.5
0.58
16
186
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
62
0.81
0.08
4.2
2.4
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
63
0.79
0.08
1.2
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
5
63
0.79
0.08
1.4
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
5
64
0.78
0.08
1.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
20
185
1.08
0.08
1.2
2.0
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
48
501
0.96
0.08
1.0
1.0
ng/l
337.6
358.6
0.14
30
347
(21494815) CD4 cells/100 lymphocytes in Specimen
49
511
0.96
0.08
2.2
2.1
%
50.6
41.9
—
5
58
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
7
65
1.08
0.08
1.0
1.0
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
21
195
1.08
0.08
3.0
1.8
ug/l
2.0
2.5
0.49
12
113
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
56
539
1.04
0.08
1.0
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
18
166
1.08
0.07
1.2
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
6
70
0.86
0.07
1.0
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
72
0.83
0.07
1.0
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
48
500
0.96
0.07
1.9
2.1
%
15.6
14.1
0.23
16
213
(3022621) pH of Urine by Test strip
522
5169
1.01
0.07
3.7
3.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
105
1024
1.03
0.07
1.1
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
16
147
1.09
0.07
1.0
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
9
85
1.06
0.07
15.2
10.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
18
167
1.08
0.06
1.1
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
42
403
1.04
0.06
2.6
3.0
ph
7.4
7.4
0.58
12
149
(3029634) Reagin Ab [Titer] in Serum by VDRL
63
650
0.97
0.06
1.7
1.6
—
3.0
—
0
10
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
51
492
1.04
0.06
1.2
1.2
u/l
9.1
20.6
7.73
42
416
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
11
99
1.11
0.06
1.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
101
0.89
0.06
1.0
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
20
187
1.07
0.06
1.7
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
54
523
1.03
0.06
2.3
2.4
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
56
577
0.97
0.05
1.1
1.1
—
26.2
—
0
6
(3016038) Potassium [Moles/volume] in Urine
51
526
0.97
0.05
1.1
1.2
mmol/l
34.2
33.4
0.10
42
443
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
39
376
1.04
0.05
1.1
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
71
727
0.98
0.05
1.4
1.3
mosm/kgh2o
277.7
274.4
0.57
52
529
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
18
169
1.07
0.05
1.2
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
55
565
0.97
0.04
1.4
1.5
—
1417.1
—
0
7
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
37
357
1.04
0.04
2.5
2.1
ug/min
48.0
75.5
—
6
71
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
14
150
0.93
0.04
1.1
1.0
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
34
351
0.97
0.03
1.4
1.3
nmol/l
1.2
1.2
0.06
28
270
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
18
171
1.05
0.03
1.3
1.3
ug/l
176.2
356.7
—
10
96
(3013247) Albumin in CSF/Albumin in Serum or Plasma
10
108
0.93
0.03
1.0
1.1
mg/g
8.3
7.0
—
10
99
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
37
360
1.03
0.03
1.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
37
360
1.03
0.03
1.3
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
79
801
0.99
0.02
1.2
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
37
361
1.03
0.02
1.1
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
20
192
1.04
0.02
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
96
949
1.01
0.02
1.2
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
20
208
0.96
0.02
1.6
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
51
501
1.02
0.02
1.1
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
26
268
0.97
0.02
1.2
1.1
—
—
—
0
0
(4027681)
33
338
0.98
0.01
1.2
1.2
—
—
—
0
0
(4133840)
14
133
1.05
0.01
1.3
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
125
1260
0.99
0.01
2.2
2.6
umol/l
33.3
34.0
0.13
107
1048
(3009466) Valproate [Moles/volume] in Serum or Plasma
77
779
0.99
0.01
4.9
4.4
umol/l
346.9
353.7
0.19
68
674
(3051101) Glucose [Moles/volume] in Cord blood
15
143
1.05
0.01
3.9
5.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
463
4642
1.00
0.01
1.9
1.7
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
23
237
0.97
0.01
1.1
1.4
%
51.1
53.8
0.12
18
205
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
55
543
1.01
0.01
1.0
1.0
u/ml
0.1
0.2
0.77
12
118
(3000285) Sodium [Moles/volume] in Blood
11
116
0.95
0.00
1.1
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
32
326
0.98
0.00
1.1
1.5
umol/l
26.7
24.8
0.12
27
305
(3006442) Creatine [Moles/volume] in Serum or Plasma
43
436
0.99
0.00
1.4
1.6
—
64.3
—
0
31
(3035320) C reactive protein [Mass/volume] in Body fluid
54
546
0.99
0.00
3.5
2.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
15
150
1.00
0.00
1.1
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
15
147
1.02
0.00
1.1
1.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
10
100
1.00
0.00
1.1
1.2
—
—
—
0
0
(44806420)
24
238
1.01
0.00
2.7
2.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
19
194
0.98
0.00
1.0
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
11
114
0.96
0.00
5.5
7.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
35
351
1.00
0.00
2.3
2.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
306
3057
1.00
0.00
1.8
1.9
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
49
489
1.00
0.00
1.5
1.9
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
51
505
1.01
0.00
1.2
1.2
u/l
59.9
82.7
2.91
41
439
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
12
125
0.96
0.00
1.2
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
20
198
1.01
0.00
1.8
1.6
ug/l
9.4
8.7
0.39
20
198
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
55
546
1.01
0.00
1.5
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
70
701
1.00
0.00
1.2
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
20
205
0.98
0.00
1.2
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
20
205
0.98
0.00
1.3
1.1
—
—
—
0
0
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
8
82
0.98
0.00
3.0
2.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
66
0.91
0.00
1.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
6
59
1.02
0.00
1.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
9
90
1.00
0.00
1.0
1.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
7
76
0.92
0.00
1.3
2.4
—
—
—
0
0
(3036005) Urine sediment comments by Light microscopy Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
6
64
0.94
0.00
1.0
1.2
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.4
—
80.6
—
0
9
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
8
89
0.90
0.00
5.4
6.7
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
30.2
—
0
5
(3009992) Blasts/100 cells in Bone marrow
0
8
0.00
0.00
0.0
2.0
—
11.1
—
0
8
(3034614) HLA Ag [Interpretation]
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
119.0
—
0
6
(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
5
52
0.96
0.00
1.2
1.4
mmol/l
181.6
149.4
—
5
44
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
33.8
—
0
5
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759632) Porphyrins [Mass/mass] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
59
0.85
0.00
4.0
2.1
—
—
—
0
0
(3001729) Color of Synovial fluid
6
65
0.92
0.00
1.0
1.7
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
7
73
0.96
0.00
1.0
1.2
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint E4_GOITREMULTINOD and mortality.

Females

Parameter HR [95% CI] p-value
E4_GOITREMULTINOD 0.943 [0.87, 1.02] 0.167
Birth year 0.992 [0.98, 1.0] 0.055

During the follow-up period (1.1.1998 — 31.12.2019), 3745 out of 27526 females with E4_GOITREMULTINOD died.

Males

Parameter HR [95% CI] p-value
E4_GOITREMULTINOD 0.966 [0.87, 1.07] 0.519
Birth year 0.987 [0.98, 1.0] 0.014

During the follow-up period (1.1.1998 — 31.12.2019), 982 out of 5001 males with E4_GOITREMULTINOD died.

Mortality risk

Mortality risk for people of age

years, who have E4_GOITREMULTINOD.

N-year risk Females Males
1 0.095% 0.187%
5 0.505% 1.23%
10 1.242% 2.97%
15 2.22% 5.37%
20 4.119% 8.844%

Relationships between endpoints

Index endpoint: E4_GOITREMULTINOD – Nontoxic multinodular goitre

GWS hits: 55

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data